A chemical investigation of a KwaZulu-Natal medicinal plant, Momordica foetida Schum. & Sond. by Sewram, Vikash.
A chemical investigation of a KwaZulu-Natal
Medicinal plant, Momordica,[oetida Sehum. & Sond.
by
VlKASH SEWRAM
Submitted in partial fulfillment of the requirements
for the deg:ree of
MASTER OF SCIENCE
in the
Department of Chemistry and Applied Chemistry,




The experimental work described in this thesis was carried out in the
Department of ChemistIy and Applied Cht:~mistIy, University of Natal, Durban
under the supervision of Professor R. Osborne and Doctor D.A. Mulholland.
These studies represent original work by the author and have not been submitted
in any other form to another university. Where use was made of the work of
others it has been duly acknowledged in the text.
Signed:~~~·~-=~/ ~
V.Sewram





I would like to express my appreciation to my supervisor, Professor R. Osbome,
and co-supervisor, Doctor D.A. Mulholland, for their invaluable assistance,
guidance and support during the course of this project.
In addition I wish to thank:
Professor K.H. Pegel for his helpful suggestions with respect to my research.
Mr D. Jagjivan for running the NMR spectra.
Dr P. Boshoff of the Cape Technikon for running the mass spectra.
Mr R. Somaru for assisting with optical rotations on my compounds.
Mrs G. Ross and Professor M. Raynor for allowing the use of the FTIR
spectrophotometer.
Mr B. Parel for his assistance in the organic research laboratory throughout the
year.




Momordica foetida Schum. & Sond. (Cucurbitaceae), locally known as
iNtshungu, is widely used by the Zulu people of Natal-KwaZulu for the
treatment of a variety of ailments.
The dried leaves leaves and stems of this plant was subjected to soxhlet
extraction by refluxing with hexane, chloroform and methanol successively.
Thin layer chromatography of the chloroform extract of the leaves revealed a
multiplicity of compounds. The chloroform extract was further partitioned with
sodium hydroxide resulting in an organic and aqueous phase. The organic
phase, containing extract A, afforded two compounds, viz. compounds 1 and 2.
The basic aqueous fraction was neutralised and re-extracted with chloroform to
give extract B, affording five compounds, viz. compounds 3,4,5,6 and 7.
Structural elucidation was accomplished by techniques such as IH and l3C NMR
spectroscopy, HETCOR, COSY, FTIR and High Resolution Mass
Spectrometry.
Compounds 1 and 2 were identified as cucurbitane triterpenoids known as
momordicines which had been previously discovered in the related species of
this plant, Momordica charantia L. The remaining five compounds were
identified as novel compounds, although natural derivatives of compounds 6
and 7 had been isolated previously from Momordica charantia L. Compounds
3-7 were each isolated as an epimeric mixture but it was possible to select the
resonances corresponding to the major epimer. These five epimers were





diene-3J3-o1 [105] and 5,19-epoxy-19(R),25-dimethoxy-5J3-cucurbita-6,23-
diene-3J3-o1 [106].
Appropriate reactions were performed, where possible, on the compounds
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[83) Momordin I R1= COOH
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Despite the dramatic advances made in orthodox medicine over the past
100 years, there has been an increasing interest in' alternativ~ systems1•
About 80% of the world's population relies on herbal medicines and
governments of third-world countries, unable to sustain a complete
coverage with western type drugs, have encouraged the rational
development of traditional treatments2• The development and application
of scientific methology to validate the medicinal and document the
toxicological properties of traditional drugs is an important requirement
for improving the quality of traditional medical practices.
The plant kingdom constitutes an abundant source of new chemical
products which may be important due to their biological properties and in
particular because of their potential use in medicine3. Traditional
medicine in general is still poorly explored in terms of therapeutic
potential or clinical evaluation. The extensive practice of traditional
medicine in developing countries and the rapidly growing demand for
basic and alternative therapeutic substances give importance to research
and development in the field of traditional drugs4• An additional
motivation is found in the practical necessity to integrate the potential of
traditional medicine into current practices of modem health care. In this
respect there are a number of facts to be considered.
Firstly, there is the daily reality of empirical practices of traditional
medical systems among many millions of people in developing countries2.
These medical provisions cover a tremendous demand for health care,
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both preventive and curative in nature. Secondly, traditional medical
practices are well adopted in the respective cultural societies5, and thirdly,
when not free of charge, the cost of these practices and drugs are, III
general, within the financial means of the people.
The continent of Africa provides an extremely diverse range of plants that,
over the centuries, has found use in curing a wide variety of ailments.
Furthermore, traditional healers are acceptable, accessible and greatly
utilised by African people and hence play an important role in tribal
communities6• Unlike the orthodox practitioners, inyangas and sangomas
never view man as separate from the earth but as an integral part of it.
Man's interelationship with his enviroment is therefore incorporated into
their healing philosophy. It is this holistic approach, routed in religion and
cultural methodology, that makes the sangomas an important component
in modem health care today.
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CHAPTER 1. The Cucurbitaceae and the
cucurbitacins
1.1. The Cucurbitaceae
The plant family Cucurbitaceae, the gourds, comprise about 100 genera
and 850 species, primarily of pantropical and subtropical distributions
with range extensions into the temperate northern and southern
hemispheres7 . None of the genera is particularly large, the larger
including Cayaponia (70 spp.), Melothria (60 spp), Gurania (49 spp),
Cyclanthera (40 spp), Trichosanthes (25 spp) and Sicyos (35 spp). In
southern Africa, the family is represented by 18 genera and 76 species8.
Representatives of the genera Zehneria, Kedrostis, Acanthoicyos,
Momordica, Citrullus, Cucumis, Trochomeria, Lagenaria, Corallocarpus,
Peponium and Coccinia are widely distributed throughout Africa while
species of Dactyliandra and Cyclantheropsis are confmed to Namibia.
Species of Gerrardanthus, Oreosyce, Mukia, Ctenolepis and Cucumella
have a scattered distribution in the Cape, Transvaal, KwaZulu-Natal and
Botswana.
The gourd family is distinguished by characters which include a prostrate
or scandent growth habit, tendril-bearing herbaceous stems, unisexual
flowers with an inferior ovary, with generally three parietal placentae
almost filling the locule and the unisexual modifications of the
androecium9• The Cucurbitaceae was subdivided by Pax (1889)7 into five
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subfamilies (Fevilleae, Melothrieae, Cucurbiteae, Sicyoideae, and
Cyclanthereae).
Economically, the family is important as a source of food and
ornamentation. Prominent among the food items are pumpkin and squash
(Cucurbita); cucumber, gherkin and maskmellon (Cucumis); and
watermelon and citron (Citrullus)lO. Species of about 16 other genera are
grown as ornamentals, mostly as gourds, including the Chinese
watermelon (Benincasa), ivy gourd (Coccinea), squirting cucumber
(Ecballium), calabash gourd (Lagenaria), dishcloth gourd (Luffa), balsam
apple (Momordica) and the snake gourd (Trichosanthes?
The potent physiological activity of plants belonging to the Cucurbitaceae
has been known since antiquity. They were feared on account of their
high toxicity and yet valued because of the medicinal properties ascribed
to them, as illustrated by examples of plants found in southern Africa
(Table 1). Pharmaceutical preparations, which are still used in modem
medical practice, include colocynth from Citrullus co10cynthis, bryonia
from species of Bryonia and elaterium from Ecballium elaterium 1o •
Bitterness occurs sporadically in cultivated cucurbits, sometimes
presenting a real danger to human health11. It appears that the amount of
bitter principles in the Cucurbitaceae is controlled by a combination of
genetic, enviromental and developmental factors l2 •
Interest in these substances was promoted by the discovery at the National
Cancer Institute, Bethesda, USA, that some compounds possess
anti-tumor activity13 • These bitter principles, occurring very widely in the
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Cucurbitaceae, have been named cucurbitacins followed by various letters
according to the chronology of isolation, although other names have
sometimes been used. Following the elucidation of their structures,
cucurbitacins have been found also in the Primulaceae'4 and Rosaceae'5
and thus seem to have a wider distribution in the plant kingdom than first
thought.
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Table 1. Ethnomedical properties of some Cucurbitaceae plants found in
southern Africa
Botanical name Common Locality Ethnomedical
name properties
Colocynthis citrullus wild gourd Cape Province remedy for arthritic
O. Ktze watermelon Namibia pam, ophthalmia,
(Citrullus vulgaris asthma, bronchitis
16
Schrad.)
Cucumis africanus L.f. wild cucumber Transvaal used as an emetic
(c. hookeri Naud.) jelly melon Swaziland and purgative17.
uhufafa, Indians in Natal use
umaselwana (Zulu) the boiled leaves as
uthangazana (Xhosa) a poultricelO .
mukake (Venda)
Cucumis hirsutus Sond. wild cucumber Zimbabwe used for constipation
Transvaal abdominal pains,
venereal diseases18
Acanthosicyos herero cucumber Namibia thirst quencherlO,
naudiniana Sond. wild melon Botswana, OFS, used as a remedy
(Citrullus naudinianus mokapana (Tswana) Transvaal, for hypoglycaemia19
(Sond.) Hook f.) KwaZulu-Natal,
Cape Province
Cucumis myriocarpus bitter apple Botswana, used as a purgative,
Naud. wild cucumber KwaZulu-Natal, emetic and applied
isendelenja (Zulu) OFS, Lesotho, to boils1o,19
monyaku (Sotho) Transvaal,
E. Cape
l,Lagenaria siceraria bottle gourd Transvaal used as pectorol,
(Molina) StandI. calabash purgative and






Cucurbita pepo L. pumpkin, squash cultivated used as a remedy for
convar. marrow hypertrophy of the
ithanga (Xhosa) prostrate gland as
umlibalamathana well as a diuretic





Studies of the cucurbitacin group of compounds, first undertaken by
Enslin (1957)ZO, have given much information on their structures. Despite
this, the molecular formula of elaterin and other cucurbitacins remained
uncertain for many years, until Rivett and Enslinz1 assigned tentative
formulae (Table 2) for the crystalline cucurbitacins on the basis of X-ray
studies. Several of these formulae have been revised successfully as
discussed in this text.
Table 2. Tentative and revised formulae of crystalline cucurbitacins
Crystalline Tentative formulae Revised formulae
cucurbitacins
A C32H460 4 C32H460 9
B C32H4gOg C32H46Og
C C3zHsoOg C32H4gOg







Rivett and Enslin also stipulated that all bitter principles contain two or
more alcoholic hydroxyl groups and cucurbitacins A,B,C and E contain
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one acetoxy group. The presence of several keto groups is a further
characteristic structural feature of these substances. In cucurbitacins
A,B,C,D,E,F and I, one of the keto groups is a,~-unsaturated.
Cucurbitacins B,D,E,G,I,J,K and L contain a diosphenol (a-diketone)
grouping which can combine with glucose or other monosaccharides to
form naturally occurring enolglycosides12• The formation of senecio
aldehyde [1] on oxidation of cucurbitacins A and C with chromic acid
threw light on the nature of the side chains present.
The isolation of 1,2,8-trimethylphenanthrene from the dehydrogenation
product of reduced cucurbitacin A indicated a possible structural
relationship to the tetracyclic triterpenes22 . Elaterin (cucurbitacin E),
isolated from Ecballium elaterium and Citrullus colocynthis was the first












In 1960, in a communication dealing with the NMR spectrum of a
compound containing a diosphenol chromophore, Noller and co-workers24
observed that the olefinic proton involved in the ring A diosphenol system
appeared as a doublet 85,97 (J=3Hz), an observation which required the
presence of an adjacent proton at C-l O.
One year later Lavie et al.25 (1961) proposed structure [2b], consistent with
the NMR observations and provided chemical and spectroscopic evidence
for the location of a methyl group at C-9 instead of C-I O. The
cucurbitacins were thus the first representatives of tetracyclic triterpenoids
with a C-9 methyl group. The carbon atom of this methyl group by
convention on cucurbitane compounds is numbered as C-19. Final
assignment of the ring C carbonyl to C-ll was given in 1962 by the same
group26.
At least 100 plant species in 30 genera and at least 3 families have been
shown to contain cucurbitacins. It is thought that the cucurbitacins were
selected for evolutionary processes in order to protect the Cucurbitaceae
against attack by invertebrate and vertebrate herbivores27.
The cucurbitacins are a biologically important group of highly oxygenated
tetracyclic triterpenoids having a unique 19(1 H 9B) abeo-lOa-lanostane
(cucurbitane) skeleton [3] and a wide range of biological activities28,29.
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A number of cucurbitacins occur in the form of glycosides, and some of
them lack the C-II carbonyl function30 • Chemically, cucurbitacins are
classified according to the functionalities in ring A and C, side chain
modifications, as well as stereochemical considerations.
1.2.2. Structure determination of cucurbitacins
1.2.2.1. The side chain
The identification of the eight-carbon atom side chain of the cucurbitacins
and its substitution pattern was based on reactions given in Scheme 1a and
1b. Following different cleavage reactions, the major fragment of the
molecule afforded different compounds depending on the starting material
and the reaction conditions.
Treatment of elatericin A [4] with periodic acid induced cleavage of the
C-20, C-22 bond with formation of a methyl ketone [5] and of
trans-4-hydroxy-4-methyl-pent-2-enoic acid [6a]. Hydrogenation of [6a]
afforded isocaprolactone [7] which was obtained in turn by hydrogenation
of the acetylenic acid [8]31,32. A similar oxidation performed on
cucurbitacin B [9] afforded the corresponding acetate [6b] identified by
hydrolysis to the original acid [6af3. Similar results were obtained with
cucurbitacin A [10]; C [11]; E [2b] and their acetates, thus confirming that





















Scheme 1a. Degradation products of the side chain of elaterin
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Further information on the nature of the side chain was obtained by alkali
treatment of elaterin [2b] (Scheme 1b). This reaction, which resulted in
the isolation of ec1?allic acid [16] (partial structure [13]) and acetoin
[15]20,35, was brought about by cleavage of the C-23, C-24 bond, and could















Scheme 1b. Degradation of the side chain of elaterin
The first step of this reaction was the hydration of the /123 bond to a
mixture of 24-0H isomers [12]36,37. The retro-aldol cleavage of the
24-hydroxy-22-one moiety present III [12] gave 2-hydroxy-
isobutyraldehyde [14] which, under the alkali conditions of the reaction,
underwent an acyloin rearrangement to give acetoin [15]. This was
confirmed by alkaline treatment of a synthetic sample of [14]37. Further
proof of the structure of the side chain was provided by ozonolysis of




1.2.2.2. The ring A substituents
Ring A substituents compnse either the a-hydroxyketones [4], [9],
characterised by the formation of a formazan with triphenyltetrazolium
chloride, or the diosphenols [2b] which give a deep green colour with
ferric chloride38 •
1.2.2.3. The 19-methyl group and ring C carbonyl
The placing of the 19-methyl group at C-9 and of the ring C carbonyl at
C-ll was based on a series of independent experiments performed on
derivatives of elatericin A [4]39,40 and cucurbitacin A [10]41 (Scheme 2).
The triketone [17] yielded only a bisethylene-ketal [18] thus revealing the
hindered nature of one of the ketones. Lithium aluminium hydride
reduction to [19] followed by dehydration produced a compound with a
double bond in ring C. The N1\1R spectrum of the diketone [20] obtained
after hydrolysis of the ketal groups exhibited an AB pattern for the two
vinylic cis protons (H-ll and H-12) thus indicating that no vicinal proton








Scheme 2. Reactions of ring C carbonyl
The formation of a C-ll, C-12 double bond in [20] left two possibilities
for the ring C ketone, either at C-ll or at C-12. Its assignment to C-ll





1.2.2.4. The ring B double bond and 16-hydroxy group
Reactions which pennitted assignment of the ring B double bond to the
5,6-position also established the absence of a methyl group at C-IO, a
characteristic feature of the cucurbitane skeleton. Oxidation of
cucurbitacin B acetate [9b] with Cr03 afforded "cucurbitone B" [22]42
(Scheme 3) which rearranged with methanolic HCI to the conjugated
dienedione [24]. The mechanism proposed for the fonnation of the latter
is based on the intennediate enol [23]. The dienedione [24] was reduced













Scheme 3. Reactions of ring A and B
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The relationship between the 5,6-double bond and the gem-dimethyl group
in ring A was demonstrated by means of the nitrile [28], formed as a result
of the Beckmann rearrangement of the 3,20-bisoxime [26]39 (Scheme 4).
Whereas the 20-oxime, in the presence of p-toluene-sulfonyl chloride,
afforded the expected enamine, leading to the 17-ketone, the 3-oxime
underwent an abnormal rearrangement [27] which resulted in cleavage of
ring A to [28]. A DV band of the latter was characteristic of a conjugated
diene; the nature of this chromophore was confirmed by the appropriate









Scheme 4. Beckmann degradation of3,20-bisoxime
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The location of the hydroxy group at C-16 was based on reactions
perfonned on different degradation products obtained from several of the
cucurbitacins analysed38,43,44.
1.2.3. Stereochemistry of the Cucurbitacins
In the presence of ethanolic potassium hydroxide at room temperature, the
triketoaldehyde [29] (a derivative of cucurbitacin C) afforded two
isomeric enolic compounds [31] and [32] (Scheme 5). This conversion
which was fonnulated as an intramolecular transfer of a p-fonnyl group
implied the presence of two keto groups. The readily enolisable 3-ketone
enabled the anionic 2-carbon atom to attack the formyl group with
formation of the intermediate aldol [30]. By cleavage of the C-9, C-19
bond in the latter, the formyl group is transferred to C-2. As expected, the
reaction did not take place with the 3-hydroxy analogue of [29]. The
transfer of the fonnyl group ([29]~ [30]~[31D greatly contributed to the
elucidation of the stereochemistry of rings AIB and B/C. lbis reaction
could only take place if the B/C ring fusion is cis with the fonnyl group at
position 9 and consequently the hindered ketone at C-II. Furthennore,










Scheme 5. Reaction of [29] showing intramolecular transfer of ~-formyt group
As stated earlier, the cucurbitacins possess the 19-methyl group at position
C-9 and a hydrogen at position C-I0; moreover, these two substituents had
to be in a trans relationship, in agreement with the sequence [29] [30]
[31] (Scheme 5), i.e. 1Oa-H, 9~-CH3 and 8~-H. An independent
demonstration for the a-orientation of H-l 0 was further based on optical
rotatory dispersion (ORD) measurements40 •
The B/C and CID ring fusion was also studied using ORD measurements
of the monoketone [33] and 16-ketone derivative [34] respectively. The
compounds were found to be orientated as follows: 8~, 9~, 13~, 14a.
Hence a lanostane - type fusion was indicated23,40.
[33] [34]
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The orientation of the side chain at C-17 was studied using the Cotton
effect40 • Based on these results, the orientation was found to be ~.
To establish the stereochemistry of the 16-0H, the molecular rotation shift
resulting from its acetylation was compared with that observed for similar
groups in steroids, leading to the conclusion that this group was
a-orientated.
1.2.4. Cleavage of the side chain
An interesting aspect of the chemistry of the cucurbitacins is the
opportunity for intramolecular attack on the 22-one by the 16a-OH with
the formation of a "pseudo-glycol" [35]. The formation of the 16-ester
[36] following lead tetraacetate cleavage of [11] has been interpreted as
taking place through cleavage of C-20, C-22 bond in [35]45. Under
alkaline conditions the 16-ester [36] was removed and the product
dehydrated to the corresponding L116-20-one [37] (Scheme 6).
20







Scheme 6. Cleavage of the side chain
1.2.5. Cucurbitacins G and H
These two isomers [38] have been isolated from roots of Cucumis hirsutus
Sond. in which they occur together with cucurbitacins B and D (elatericin
A)46. They are both a-hydroxy ketones (positive triphenyltetrazolium
cWoride test) and do not display the characteristic 230 nm band for the
a,J3-unsaturated carbonyl of the side chain.
Cucurbitacins G and H
[38]
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1.2.6. Cucurbitacins J, K, and L
Cucurbitacins J, K and L, which possess a diosphenol grouping in ring A,
occur as bitter glycosides in the roots of Citrullus ecirrhosus Cogn. and
have been isolated by enzymatic hydrolysis47 • They have also been
obtained directly as the free aglycones from the roots of Bryonia dioica
Jack.48 , in which they occur probably as glycosides but with the glycosidic
bond cleaved by the enzyme elaterase in the plant.
Cucurbitacin L [39] occurs in Citrullus colocynthis (L.) Schrad. together
with elaterin [2b] and cucurbitacins I [40] as the corresponding

















This compound [42) was isolated from Marah oreganus H., where it
occurs together with other cucurbitacins50 . The structure was established
by comparison with an authentic sample prepared by the catalytic




This compound was first isolated from Luffa echinata Roxb.52 and
erroneously assigned a 3-keto-2(axial)-hydroxy structure. Subsequently,
the same compound was isolated from Marah oreganus and assigned
structure [43)53 on the basis of reduction experiments carried out with
diosphenol- containing systems.
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1.2.9. 22-deoxocucurbitacin D and
22-deoxoisocucurbitacin D
The two cucurbitacins [44] and [47] were isolated together from a hybrid
obtained by the crossbreeding of two varieties of Lagenaria siceraria
Stand1.54• Upon treatment with dilute acid, [44] underwent a
rearrangement involving the elimination of the tertiary 25-hydroxyl and
formation of a C-16, C-23 bond in a six membered ring ether [45].
The involvement of the C-16 hydroxy group was demonstrated by








Scheme 7. Rearrangement of 22-deoxocucurbitacin 0
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22-deoxocucurbitacin D [47], when treated with dilute acid, behaved
similarly to [44] and gave the anhydro-derivative [48a] (Scheme 8).
Acetylation of the latter afforded a monoacetate [48b] which displayed a







[47] [48a] R= H
[48b] R=Ac
Scheme 8. Rearrangement of 22-deoxoisocucurbitacin D in acidic conditions
1.2.10. Cucurbitacins F, 0, P and Q
The distinguishing feature of these cucurbitacins is the presence of a
2,3-diol system in ring A. They all occur in nature as free aglycones.
Cucurbitacin F [49] was isolated from the leaves of Cucumis dinteri
Cogn.55 and was later found in Cyaponia angustiloba Cogn.56, whereas the
other three compounds ( i.e. cucurbitacin 0 [50], cucurbitacin P [51],




















This compound was isolated from Bryonia dioica Jacq.58 and was initially
assigned structure [53] on the basis of chemical and spectral evidence.
[53]






It was suggested that cucurbitacin S could not have been a natural
compound59 • A plausible hypothetical natural compound could be [55],
which may serve as a parent for cucurbitacin S by cyclization and acetal










Scheme 9. Suggested preparation of Cucurbitacin S and other artefacts
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1.2.12. Cucurbitacin T
This compound [59] was isolated from fruits of Colocynthis vulgaris




It was assumed that [59] was an artefact formed from [40] during acid
treatment of ~he methanolic extract. However, the artefactual origin of
[59] was ruled out as the treatment of [40] with IM sulphuric acid in
methanol did not afford even trace amounts of [59]60.
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1.2.13. Bryodulcosigenin, bryosigenin, bryogenin
These compounds exist in nature as glycosides and have been grouped
together according to their substitution pattern. They all possess an axial
hydroxy group at position 3 and lack the C-16 hydroxyl group. The eight
carbon atom side chain is at a lower oxidation level than in other
cucurbitacins.
Bryodulcosigenin [60] has been isolated from the roots of Bryonia dioica
Jack. following enzymatic hydrolysis of the glycoside bryodulcoside61,62.
Bryosigenin [61] has been obtained as a minor component from the above
mixture. The relationship between [60] and [61] was established by
converting the latter to the former using sodium borohydride at ice bath








Scheme 10. Relationship between cucurbitacins from Bryonia dioica Jack.
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Hydrolysis of [60] yielded bryogenin [62] suggesting that [62] does not
occur in nature but is the product of the dehydration of the
secondary-tertiary glycol system present in the side chain of [60]63.
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1.3. Biosynthesis of cucurbitacins
1.3.1. Introduction
It has been shown that 10a-cucurbita-5,24-dien-3(3-01 [63] represents the
parent compound of cucurbitacins64 •
HO
[63] 1Oa-cucurbita-5,24-dien-3~-ol
1.3.2. Cyclization of squalene-2,3-epoxide to [63]
Triterpenoids were found to originate biogenetically from the 30 atom
compound squalene [64], a tail -to- tail condensate of farnesol, which is a
sesquiterpene alcohol.
[64] Squalene
By obtaining labelled 10a-cucurbita-5,24-dien-3(3-01 from [3-3H]
squalene-2,3-epoxide incubated with microsomes of Cucurbita maxima
Duch. ex Lam. seedlings, Balliano and co-workers65 were able to propose

























Scheme 11. Proposed route for the biosynthesis of cucurbitacins
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They concluded that squalene-2,3-epoxide [65], folded ill a
chair-boat-chair-boat confirmation, cyclized to give the carbocation [66].
This is then stabilised by methyl and hydrogen migrations (H-17~H-20;
H-13--)H-17; Me-14-7Me-13; Me-8~Me-14; H-9~H-8) yielding a
lanostane C-9 carbonium ion [67], which is bonded to the enzyme by a
suitable nucleophilic group. Withdrawal of the enzyme could then allow
the further migration of the C-IO methyl group to C-9, according to the
rules of Wagner-Meerwein rearrangements. The subsequent hydrogen
migration from C-5 to C-IO and elimination of the C-6 proton by a basic
site of the enzyme will give lOa-cucurbita-5,24-dien-3~-ol [70] (route C),
the parent compound of cucurbitacins.
Alternatively, loss of the C-ll protons from [67] (route A) could give
parkeol [68]. The migration of the C-IO methyl to C-9, induced by an
electron deficiency at C-9, followed by hydrogen migration (H-5-4H-IO)
and elimination of a C-6 proton, will give the cucurbitane skeleton [70].
Since parkeol was not found in Bryonia dioica Jack,66, Cucurbita maxima
Duch. ex Lam.45 nor in Cucumis sativis L.s, even in trace amounts, route A
was considered to be hypothetical.
The next possibilty could include loss of a proton from the C-19 methyl
group (route B) with closure of the 9~,19-cyclopropane ring to give
cycloartenol [69], the supposed general precursor of phytosterols67. Such
an intermediate as [69], by opening of the 9~, 19-cyclopropane ring in
concert with hydrogen migration and proton elimination, could lead to
[70]. However, the opening of the cyclopropane ring in [69] is inhibited
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by the presence of the 4J3-methyl group32 thereby decreasing the
possibility of route B.
The results obtained by Balliano et al. lead to the conclusion that the
biosynthesis of cucurbitane triterpenoids from squalene-2,3-epoxide
occurs through direct cyclization by an enzyme very similar to
squalene-2,3-epoxide-cycloartenol synthetase without the intermediacy of
lanostane-type triterpenoids such as cycloartenol [69] or parkeol [68].
An elaboration of route D can be seen in Scheme 12. The side chain of
[71] is transformed to produce different end products.





























Biosynthetically, cucurbitacin T [59] could originate from eith-er
cucurbitacin I [40] or J [41] as shown in Scheme 13. The co-occurrence














Scheme 13. Biosynthesis of Cucurbitacin T
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1.4. Biological activity of cucurbitacins
Cucurbitacins were reported to exhibit high cytotoxicity against tumor
cells. Studies on the antitumor effect of cucurbitacins undertaken by
Gitter and co workers68 showed that elatericin A [4], elatericin B[75] and
elaterin [2] isolated from Ecballium elaterium L. and Citrullus colocynthis
O. Ktze. produced a moderate inhibition of growth of Sarcoma 180,
Sarcoma Black and Ehrlich ascites carcinoma. Sarcoma 180 proved to be
the most sensitive tumor. These observations support the ethnomedical
claims of these plants as a treatment for cancer.
Further studies undertaken by Gallily et al.69 have shown that elaterin
methyl ether (EME) [76] is the most active antitumor compound of the
cucurbitacin derivatives studied. Dihydroelaterin A [77] and
dihydroelaterin methyl ether (DEME) were the least effective.
It could therefore be concluded that the methylation of the enolic hydroxyl
group of elaterin enhances its antitumor activity. The cytotoxic and
antitumor activities are also dependent on the existence of a double bond
in the side chain of these compounds since hydrogenation of the Li23 ,24
double bond was accompanied by a significant decrease in cytotoxicity of
the resultant dihydrocucurbitacin and DEME. Furthermore, acetylation of
the CI6a-OH group of cucurbitacin B produced fabacein70 with marked
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diminution of cytotoxicity, indicating that the u,p-unsaturated ketone
system is activated by hydrogen bonding between the C16u-OH group








[77] Dihydroelatericin A [78] (DEME)
Shohat et al.71 studied the combined effect of cucurbitacins and X-ray
treatment on transplanted tumors in mice and found that the tumor
growth-inhibitory effect of the combined treatments was more pronounced
at all levels than that obtained by applying the corresponding doses of
X-rays or cucurbitacins separately.
In 1981, Witkowski and Konopa72 studied the mode of cytotoxic action of
cucurbitacins and found that it involved their binding with glucocorticoid
receptors of sensitive cells.
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The alcoholic extracts of Cucumis trigonus Roxb. exhibited a marked
analgesic effect when tested using pethidine hydrochloride as a standard
drug73 . In addition, the extract showed a significant anti-inflammatory
activity against both exudative and proliferative manifestations of
inflammation and the activity compared very favourably with the
non-steroidal anti-inflammatory agent, phenylbutazone [80].
[80] Phenylbutazone
Preliminary chemical tests of the extract revealed the presence of
glycosides and tannins which may be reponsible for the actions reported.
Yesilada et a1.74 isolated cucurbitacin B [9] from the fruit juice of
Ecballium elaterium L. and found this compound to have
anti-inflammatory principles.
Studies are presently being undertaken to determine whether the seed
extracts of different Cucurbitaceae plants invariably possess protein
synthesis inhibiting (i.e. ribosome inactivating protein-like) activity75. The
ribosome inactivating proteins have been gaining importance because of
their interesting and potentially useful biological activities which comprise




abortifacient, and protein synthesis inhibiting
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Chapter 2. The Genus Momordica
2.1. Introduction
Momordica L., a genus restricted naturally to the Old World, is widely
distributed in Africa. Several species of the genus are thought to have
been introduced to the New World with the slave trade from Mrica to
Brazils3 • Bird dispersal of the seeds of wild or domesticated forms may
account for the spread of the species within continents. The plants are
perennial herbaceous climbers with simple to hairy stems. The flowers
and fruit vary with different species19 • Three species, viz. Momordica
cochininensis Spreng., Momordica charantia L. and Momordica foetida
Schum. & Sond. are widely used medicinally. The latter species is the
least investigated.
2.1.1. Momordica cochininensis
Momordica cochinchinensis Spreng. is a perennial climber occurring from
China to the Moluccas and has been used in traditional medicines in East
and Southern Asia79 • The seeds are considered to have cooling properties
and are used as a remedy for fluxes, liver and spleen disorders,
hemorrhoids, bruises and swelling80.' The Chinese call the crude drug
mubiesi and the Japanese call it mokubesi81 • The roots of this plant were
also used therapeutically in Japan as an effective antitussive expectorant82 •
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Investigations into the chemical constituents of this plant have revealed
the presence of pentacyclic triterpenoids and their glycosides. Studies
carried out by Murakani and colleagues (1966)81 on the seed of this plant
resulted in the isolation of momordic acid [81], the first example of a
triterpenic acid having a I-oxo group in the oleanane series.
HO
[81] Momordic acid
A Wolff-Kishner reduction (Scheme 14) converted momordic acid into a
compound [82], C30H4803, which was subsequently identified as oleanolic
acid. This confirmed that [81] was the I-oxo-derivative of oleanolic acid.
[81] momordic acid [82] oleanolic acid
Scheme 14. Wolff - Kishner reduction of momordic acid
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Further studies undertaken by Masayo et al. (1985)80, resulted in the
isolation and structure elucidation of three saponins named momordins I
[83], IT [84], ill [85]. Their structures were determined on the basis of
chemical and spectral evidence as oleanolic acid 3-0-a-L-
arabinopYfanosyl(1---) 3)-B-D-glucuronopyranoside [83]; 28-0-B-D-
glucopYfanoside of momordin I [84] and 3B-hydroxy-Ila,12a-epoxy-







[83] Momordin I R1 =eOOH
[84] Momordin 11 Rz = H
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2.1.2. Biological activity
Ng and co-workers (1986)83 reported the presence of saponins with
hemolytic activity in the tubers of Momordica cochininensis Spreng..
This hemolytic activity was due to steryl glycosides. This hemolytic
fraction contained proteins as judged by its high absorbance at 280 nm and
by its SDS - polyacrylamide gel electrophoretic and immuno-
electrophoretic profiles.
In the same year, Reza-ul-Jalil and associates84 isolated two glycosides
containing oleanolic acid as the aglycone. One glycoside, named MG-1,
contained glucose and the other, MG-2, contained glucose and arabinose.
Both these glycosides showed hypoglycaemic activities in streptozotocin
induced diabetic rats at a dose of 25 mg/kg. MG-1 was found to be more
effective than MG-2. This difference in potency could be attributed to
their difference in polarity, the latter being more polar and hence less
permeable through biological membrane. These glycosides however
lowered haemoglobin content and produced focal necrosis in the liver.
In 1987 Yeung et al. 85 isolated an abortifacient protein from the root tubers
of Momordica cochininensis Spreng. which they designated as
momorcochin. This was found to be the least basic abortifacient protein.
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2.2.1. Momordica charantia
Momordica charantia L., the African cucumber or balsam pear86, is
widely distributed in West Africa, India and Japan. The leaves contain
antibacterial and insecticidal principles lO • In Japan, the plant is used in a
remedy for skin ailments, headache and constipation87 and as an
antidiabetic agent88.
A number of cucurbitane triterpenoids named momordicosides and
momordicines have been isolated from the fruits and leaves of this plant.
Momordicosides K [86] and L [87], isolated as bitter principles from
immature fruits of M charantia L., have been characterised as unique
cucurbitacins having a formyl group and a 7-O-J)-D-glucopyranosyl
moiety89.
[86] Momordicoside K
7-O-~-D-glucopyranoside of 3~ ,7~-dihydroxy-25-0-methyl-eucurbita-5.23-dien-19-al
HO
[87] Momordicoside L
7-O-~-D-glucopyranoside of 3~ ,7~-25-trihydroxy-cucurbita-5,23-dien-19-al
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In 1982, investigations undertaken by Okabe et al.90 resulted in the
isolation of four non-bitter cucurbitacins designated momordicosides F1
[88], F
2
[89}, G [90} and I [91}. These compounds were isolated in
crystalline form from the methanol extract of fresh immature fruits.
[88] F1: R1 =13-D-glucopyranosyl, R2=CH3
[89] F2: R1=I3-D-allopyranosyl, R2=H
[90] G: R1=I3-D-allopyranosyl, R2=CH3
[91] I: R1=13-D-glucopyranosyl, R2=H
Continued investigations into the chemical constituents of this plant








In 1990, studies carried out by Fatope et a1.87 resulted in the isolation of
two new compounds [96] and [97] (cucurbitane triterpenoids) from the
chloroform extract of the leaves. Compound [93] was also isolated and






Studies by Lotlikar and Rao88 on the pharmacology of the hypoglycaemic
principle isolated from Momordica charantia L. led to the conclusion that
charantin was not the only compound responsible for the hypoglycaemic
activity present in the fruits of this species.
Clinical trials in patients with diabetes mellitus were carried out by
Baldwa and co-workers92 after extraction and purification of vegetable
insulin. Although the onset of action was found to be similar to standard
zinc crystalline insulin, the peak effects were significantly different.
Khanna and Mohan93 were able to extract an abortifacient factor present in
this crude extract and one of the constituents isolated was diosgenin [98].
HO
[98] Diosgenin
A steryl glycoside fraction was isolated from the seeds by Ng and




Momordicafoetida Schum. & Sond., locally known by the Zulu people as .
iNtshungu, is a dioecious or occasionally monoecious perennial
herbaceous climber with stout, smooth or sometimes hairy stems up to 5
metres long, marked with linear dark spotsl9 • The leaves are simple, often
deeply lobed, extripulate, alternate and frequently very hairy. The flowers
are actinomorphic and unisexual and may be large and showy. The fruit is
usually a fleshy berry and is edible9 •
This plant is found in Africa south of the Sahara. In southern Africa, it
occurs in the Cape Province, KwaZulu-Natal, Transvaal and Swaziland.
The Zulus drink a decoction of the root or leaf for the treatment of boils10 •
'\.
According to BryantlO , the Zulu people take an infusion of the runner as a
sedative for irritable stomach. The leaf is a Chagga earache remedy95 and
in tropical Africa is used for roundworm96 • The Ganda of Uganda take an
infusion of the leaf and root as an abortifacient and ecbolic97• In Tanzania,
the fruit pulp is regarded as poisonous to weevils, moths and ants and is
used as a repellant98 • This plant is used in KwaZulu-Natal as a remedy
for hypertension and is also recognised for its antidiabetic properties99•
This plant is said to contain alkaloids although no substantiative proof has
been presented lOo • Previous studies on this plant resulted in the isolation
and identifiaction of 3 compounds, viz. p-sitosterol glucoside [99];
5,25-stigmastadiene-3p-ol glucoside [100] and 1P-hydroxyfriedel-6(7)-
ene-3-one [101]101,102.
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Compounds [99] and [100] were found to co-exist as a
chromatographically homogenous product named foetidin101. Compound
[101] appeared to be the first member of the naturally occuring friedelane









[1 00]5 ,25-stigmastadien-3~-ol glucoside
The friedelane nucleus could have fonned by a senes of backbone









Scheme 14. Backbone rearrangement of pentacyclic triterpenoids
showing the formation of the fi"iedelin nucleus
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2.3.2. Biological activity
Marquis and co-workers l03 studied the effect of foetidin on blood glucose
level of albino rats. It was found that foetidin had no significant
antidiabetic property when administered to alloxan treated rats but it was
capable of reducing the blood sugar level in fasting rats. These results did
not seem very promising.
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CHAPTER 3. Results and Discussion
Momordica foetida Schum. & Sond. which is grown widely in Durban
and the surrounding areas was readily obtained. Fresh plant material
was purchased at the Umlazi herbal market and the leaves were
separated from the vine before being air dried. The dried leaves were
powdered and soxhlet extracted by refluxing with hexane, chloroform
and methanol successively. The chloroform extract of the leaves was
chosen for investigation. Further partitioning of the chloroform extract
with IM NaOH resulted in two extracts (Experimental 4.7 .), viz, extracts
AandB.
Extract A yielded two compounds, [92] and [93] identified as
cucurbitane triterpenoids which had been isolated previously from the
related species, Momordica charantia L.
Extract B yielded five compounds labelled compound [102], [103],
[104], [105] and [106]. All of the five compounds were identified as
novel compounds although the natural derivatives of compounds [105]
and [106] have been isolated previously from Momordica charantia
L.90,91. Compound [105] was isolated previously as the glycoside90 while
compound [106] as the acetate91 .
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3.1. Extractives from extract A
3.1.1. Compound 1 [92]
[92]
High resolution mass spectroscopy indicated that the compound had a
molar mass of 472.3551 g.mol-1 (calculated 472.3552 g.mol-1), consistent
with a molecular formula C30H4s04' The mass spectrum (spectrum la)
displayed peaks at m/z 454 (M+-H20) and 436 (M+-2H20), due to ready
dehydration of the compound, showing that at least two hydroxyl groups
were present, and at m/z 443 (M+-CHO) due to a-cleavage of the
aldehyde group. Application of the double bond equivalence formula
indicated a double bond equivalence of seven. A positive
Lieberman-Burchard test confirmed this compound to be a triterpenoid
which was isolated as an amorphous powder.
The infrared spectrum (spectrum 1b) displayed a strong band at 3404
cm-1 indicating the presence of a hydroxyl group. Differentiation
between primary, secondary and tertiary alcohols is possible in many
cases from the position of the C-O stretching bands. In this spectrum,
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the strongest C-O band at 1084 cm-I suggested a secondary hydroxy
group. The band at 1666 cm-I indicated the presence of unsaturation.
The strong bands at 2947 cm-I and 2879 cm-I arose due to the presence
of alkyl groups and the presence of methyl groups was shown by the
complexity of bands between 1467 cm-I and 1379 cm-I. The strong sharp
band at 1709 cm-I indicated the presence of an aldehyde group. This was
further confirmed by the positive results obtained from the Tollen's test,
i.e. a silver mirror formed on the walls of the test tube due to oxidation
of the aldehyde to a carboxylate salt by the silver ion complexed with
ammonia (Tollen's reagent). The two weak bands between 2820 cm-I
and 2740 cm-I generally ascribed to the C-H stretching vibrations of an
aldehyde group were not visible due to the presence of strong bands due
to alkyl groups in the same region of the spectrum.
The BC NMR spectrum (spectrum Id) confirmed the presence of thirty
carbon atoms. The multiplicity assignments which where made from the
DEPT spectrum (spectrum le) revealed the presence of seven quartets,
seven triplets and ten doublets. The remaining six carbon resonances
were assigned as singlets. The resonances at 841.4, 49.9, 45.4 and 847.6
indicated four quaternary carbons while the resonances at 865.9, 76.1
and 866.2 were due to three oxygen-bearing carbons. This was
confirmed in the IH NMR spectrum (spectrum 1c) by resonances at
84.44 (lH, bt, JZ3,Z4=8.65Hz, H-23); 8 3.95 (lH, bs, Wl/z=8.00Hz, H-7a)
and 83.54 (lH, bs, Wl/z=7.61Hz, H-3a) respectively. The width at half
peak heights for H-7 and H-3 were 8.00Hz and 7.61Hz respectively,
indicating a orientation in each case, hence the hydroxy groups had to
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be f)-substituted. The molecular model indicated the 3f)-OH to be axial
when ring A assumed the chair conformation.
The IH NMR spectrum also showed the presence of a one-proton singlet
at 89.69 ascribable to an aldehyde proton. This was supported by the
carbon resonance at 8207 .8 (d). The nature of the carbon skeleton was
revealed by the presence of four tertiary methyl group proton resonances
at 81.22, 1.03, 0.89 and 80.73 (each 3H, s) and one secondary methyl
group proton resonance at 80.96 (3H, d) while the downfield shift of a
further two methyl groups (81.66 and 81.68, each 3H, s) suggested that
these were due to vinylic methyl group protons. The presence of two
one-proton doublets at 85.87 and 85.17 together with resonances at
8145.5 (s), 123.9 (d), 129.9 (d) and 8133.9 (s) in the 13C-NMR spectrum
revealed the presence of two double bonds. The 2D IH_1H COSY
spectrum (spectrum f) revealed that these proton resonances were not
coupled indicating that both the double bonds were tri-substituted.
The COSY spectrum (spectrum f) also revealed that the aldehyde proton
was not coupled. This meant that the aldehyde group was attached to a
quaternary carbon. The biosynthetic pathway of cucurbitacins suggested
that C-9 was the most likely quaternary carbon to which this functional
group could be attached. The orientation of the aldehyde group was
considered to be f) on the basis of cucurbitacin biosynthesis.
The expanded COSY spectrum (spectrum g) revealed coupling between
a pair of one-proton doublets at 85.87 and a broad singlet resonating at
83.95. These peaks were assigned to H-6 and H-7u respectively. The
H-6 signal was also long range coupled to a resonance at 82.52
ascribable to H-I0 due to long range coupling to H-6 across the 5,6
double bond. The H-6 signal was split into a doublet by H-7 and
thereafter further split by H-I0 (J6,7=5..l3Hz, J6,1O=1.92Hz) resulting in a
double doublet. The H-I0 signal resonated as a multipiet due to splitting
induced by H-6 as well as the two protons attached to C-l. From the 2D
lH_l3C HETCOR spectrum (spectrum h), a doublet at 836.6 could be
assigned to C-l O.
The COSY spectrum also confirmed coupling between H-24 (85.17,
J23,24=8.65Hz) and H-23 (84.44, J23,24=8.65Hz). The H-24 doublet was
also seen to be long-range coupled to the two vinylic methyl groups at
81.68 and 81.66 respectively. The two methyl group proton resonances
were assigned 3H-26 and 3H-27 respectively and correlated with
resonances at 818.1 (q) and 25.7 (q) in the HETCOR spectrum. H-23
was coupled to a multiplet at 81.61 assigned to H-22 and this signal
correlated with a carbon signal at 844.4 (t).
The doublets at 8128.9 (d) and 123.9 (d) were assigned to C-6 and C-24
by means of the HETCOR spectrum. The three doublets in the C-O
region at 876.1, 66.2 and 865.9 correlated with proton resonances at
83.54, 3.95 and 84.44 which were ascribed to H-3a, H-7a and H-23
respectively. The HETCOR spectrum also revealed that the secondary
methyl group proton resonance at 80.96 (d) corresponded to a carbon
resonance at 818.8 (q). The signals between 82.30 and 82.24 occurred
as a result of hydroxy protons since after the addition of D
2
0 to the
sample (spectrum i), these signals disappeared.
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Acetylation of compound 1 [92] yielded a triacetate [92a] (spectrum j).
This was revealed in the IH NMR spectrum by the presence of three,
three-proton singlets at 01.99, 02.00 and 02.01 ascribable to the three
proton resonances of each of the acetate methyl groups. The peaks
ascribed to H-23, H-7u and H-3u were shifted downfield to 05.55, 5.17
and 4.79 respectively on acetylation. This downfield shift occurred due
to deshielding of the protons induced by the acetate carbonyl group.
Acetylation of this compound confirmed the presence of three secondary
hydroxy groups and the fact that H-23, H-7 and H-3 shifted downfield




On the basis of all the spectral evidence obtained and the similarities
between our data to that published in literature91 , compound 1 was
assigned structure [92].
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3.1.2. Compound 2 [93]
[93]
High resolution mass spectrometric analysis (spectrum 2a) of this
compound showed that the the M+ peak occurred at m/z 472.3552
(calculated 472.3552), correct for the formula C30H4s04 as in compound
1. The mass spectrum also displayed peaks at m/z 454 (M+-H20), 436
(M+-2H20) due to ready dehydration of the compound showing that at
least two hydroxyl groups were present and at m/z 443 due to a-cleavage
of an aldehyde functional group. The molecular formula indicated a
double bond equivalence of seven. A positive Liebermann-Burchard test
suggested that the compound was a triterpenoid.
The infrared spectrum (spectrum 2b) displayed strong sharp bands at
3431 cm- l and 3273 cm-I due to OH stretching vibrations. This was
further confirmed by c-o stretching vibrations at 1134 cm- l and 1089
cm-I suggesting that at least one tertiary and one secondary hydroxyl
group was present. The band at 3067 cm-I indicated the presence of
unsaturation. The strong bands at 2955 cm-I and 2877 cm-I arose due to
the presence of alkyl groups and the presence of methyl groups was
shown by the complexity of bands between 1465 cm-I and 1375 cm-I.
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The sharp band at 1701 cm-1 was due to the carbonyl stretching
vibrations of an aldehyde group. The presence of an aldehyde was
further confirmed by the positive result~ obtained from the Tollen's test.
The two weak bands between 2820 cm-1 and 2740 cm-1 generally
ascribed to the C-H stretching vibrations of an aldehyde were not visible
due to the presence of strong bands due to alkyl groups in the same
region of the spectrum.
The IH NIvIR spectrum of this compound (spectrum 2c) was similar to
that of compound 1 except for the absence of the H-23 triplet at 84.44
and lack of the downfield shifted methyl groups indicating that no
vinylic methyl groups were present.
The l3C NIvIR spectrum (spectrum 2d) confirmed the presence of 30
carbon atoms. The DEPT spectrum (spectrum 2e) revealed seven
quartets, seven triplets and ten doublets. The remaining six carbon
resonances were assigned as singlets. The resonances at 8145.5 (s),
139.6 (d), 125.1 (d) and 8123.9 (d) indicated that there were two alkene
double bonds in the molecule, one of which was trisubstituted and the
other disubstituted. The resonances at 876.1 (d), 66.3 (d) and 870.7 (s)
occurred due to the presence of two secondary and one tertiary carbinyl
group respectively.
The IH NIvIR spectrum showed a resonance at 89.61 (lH, s) indicating
the presence of an aldehyde group which was further confirmed by a
doublet at 8207.8 in the l3C NMR spectrum. This aldehyde functional
group was attached to C-9 with f3 orientation for similar reasons as
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discussed for compound 1. The lH NMR spectrum also revealed the
presence of seven methyl groups at 80.73, 0.87, 1.03, 1.22 (3H, s,
4xCH3), 0.89 (3H, d, J=6.0Hz) and 81.29 (6H, S, 2xCH3). The spectrum
also displayed a resonance at 85.87 (lH, dd, J6,7=5.13Hz, J6,1O=1.92Hz)
ascribable to H-6 and was coupled to H-7a (lH, 83.95, bs, Wl/2=8.00Hz)
and H-l 0 (lH, 82.52, m) as deduced from the 2D lH_1H COSY spectrum
(spectntm 2t). The resonance at 85.56 (m) integrated to two protons and
correlated with carbon signals at 8125.1 (d) and 8139.6 (d) in the
HETCOR spectrum (spectrum 2g). These signals were ascribed to C-23
and C-24 respectively. Thus the proton signals for H-23 and H-24 were
superimposed at 85.56.
ill the COSY spectrum, coupling was also observed between the
resonance at 85.56 and a multiplet at 81.69. This multiplet was assigned
to 2H-22, the corresponding C-22 signal was seen to occur at 839.0 (t) in
the HETCOR spectrum. H-I0 was also coupled to a multiplet signal at
81.82 which correlated with a carbon signal at 827.4 (t) ascribable to
C-1.
The broad signal resonating at 83.55 (Wl/2=8.25Hz) was ascribed to the
equatorial H-3a. This resonance was coupled to a multiplet at 81.71
which corresponded to a carbon signal at 828.9 (t). This signal was
assigned to C-2. The carbon signal at 8123.9 (d) correlated with the
proton resonace at 85.87 which had previously been assigned to H-6.
The two doublets in the C-O region at 876.1 and 866.3 were ascribed to
H-3a and H-7a respectively from the HETCOR spectrum.
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The IH NMR spectrum displayed a sharp singlet at 81.29 (6H) which
correlated with carbon resonances at 829.8 (q) and 29.9 (q). The six
proton signal was ascribed to the 3H-26 and 3H-27 protons. Since the
disubstituted double bond was placed between C-23 and C-24, C-25 had
to have either a hydrogen or an oxygen atom present. As the 3H-26 and
3H-27 resonances appeared as a singlet, C-25 had to have an oxygen
atom attached to it. This possibility was further supported by the carbon
resonance at 870.7 (s) leading to the conclusion that a tertiary hydroxy
group was at C-25. The signal at 82.38 was due to a hydroxy proton
since addition of D20 to the sample resulted in the disappearance of this
signal (spectrum 2h).
This compound was identified as 3P,7p,25-trihydroxycucurbita-
5,23-diene-19-al which was previously isolated from the leaves of
Momordica charantia L. by Fatope et a1. 87 The 8 values for the carbon
signals were not identical since their NMR spectra were obtained in
deuteropyridine whereas our spectra were obtained 10
deuterochloroform. The rest of the peak assignments are listed in tables
3 and 5 and are in good agreement with those of compound 1 [92].
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Acetylation of this compound with acetic anhydride/pyridine resulted in
the formation of the diacetate [93a] (spectrum 2i) as seen by the two
sharp resonances at 82.01 _and 82.00 due to acetate methyl group
protons, thus confirming the presence of only two secondary hydroxy
groups. The H-7a and H-3a resonances were shifted downfield to 85.19





3.2. Extractives from extract B




This compound was obtained in larger quantities than the other four
compounds from this extract. Hence it was decided to discuss the
structure elucidation of this compound first with respect to extract B
since frequent references are made to this compound during the structure
elucidation of the other compounds.
High resolution mass spectroscopy indicated the compound to have a
molar mass of 486.3725 g.mol-1 (calculated 486.3709 g.mol-1), correct
for the molecular formula C31Hso04. The mass spectrum (spectrum 3a)
displayed peaks at m/z 471 (M+-CH3), 440 (M+-C02H2), 422
(M+-C02H2-H20) and 408 (M+-CH30H). A proposed fragmentation
scheme for the molecule is illustrated in Scheme 15. All proposed











Scheme 15. Proposed fragmentation of Compound 3
All structures were supported by high resolution mass measurements
64
The infrared sprectrum (spectrum 3b) displayed a broad band at 3292
cm-I indicating the presence of a hydroxy group. The band at 3024 cm-I
indicated the presence of unsaturation and this was confirmed by the
band at 1649 cm-I. The bands between 2949 cm-I and 2877 cm-I were
due to alkyl groups and the presence of methyl groups was shown by the
sharp band at 1375 cm-I. The band at 1080 cm-I indicated that a
secondary hydroxy group was present while the peak at 1118 cm-I due
to the asymmetric C-O-C stretching vibration suggested that an ether
linkage was present.
The BC NMR spectrum (spectrum 3d) displayed strong resonances for
31 carbons although other minor signals suggested the presence of an
impurity. Multiplicity assignments made from the DEPT spectrum
(spectrum 3e) indicated eight quartets, seven triplets and ten doublets.
The remaining six carbon resonances were assigned as singlets. The
four resonances at 0136.8 (d), 132.7 (d), 132.4 (d) and 0128.3 (d) were
due to olefinic carbons and indicated the presence of two disubstituted
double bonds. Unlike compounds 1 and 2, this compound lacked the jj,5,6
double bond. The resonances at 048.5 (s), 48.0 (s), 45.1 (s) and 037.2
(s) were due to quaternary carbon atoms and their peak assignments
were made with comparison to those of compounds 1 and 2. The
resonances 0105.4 (d), 86.6 (s), 76.1 (d), 74.9 (s) and 050.3 (q) were due
to oxygen-bearing carbons.
The IH NMR spectrum (spectrum 3c) displayed a resonance at 06.06
(lH, dd) and this was seen to be coupled in the COSY spectrum
(spectrum 3t) to a double doublet resonating at 05.65 (lH, dd). These
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resonances correlated with carbon resonances at 8132.7 (d) and 132.4 (d)
in the HETCOR spectrum (spectrum 3g). The resonances at 86.06 and
_5.65 were ascribed to H-6 and H-7 respectively based on comparison
with chemical shifts of [88J and [90tO and the first double bond was
placed between C-6 and C-7. H-6 was split into a doublet by H-7
(J6,7=9.76Hz) followed by further splitting by H-8 (J6,s=2.30Hz) due to
long-range coupling across the /:16,7 double bond . This was confirmed
by the COSY spectrum where H-6 was seen to be long-range coupled to
a broad singlet at 82.81 ascribable to H-8. This resonance at 82.81
correlated with a carbon resonance at 841.4 (d) in the HETCOR
spectrum. The H-7 signal was also split by H-6 (J6,7=9.76Hz) into a
doublet followed by further splitting induced by H-8 (J7,s=3.72Hz) as
observed in the COSY spectrum, to yield a double doublet. The facts
that both BC NMR resonances (8132.7 and 8132.4) were doublets and
the long range coupling between H-6 and H-8 rules out the possibility of
a biosynthetically anticipated 5,6-double bond.
The COSY spectrum also revealed coupling between a multiplet at 85.42
and a singlet at 85.40 with each signal integrating to one proton. These
resonances were ascribed to H-23 and H-24 respectively and
corresponded to carbon resonances at 8128.3 (d) and 136.6 (d) in the
HETCOR spectrum. Hence the second double bond was placed between
C-23 and C-24. The H-23 multiplet was also seen to be coupled to a
broad multiplet at 81.76 (2H) ascribable to 2H-22. This signal correlated
with a carbon resonance at 827.1 (t).
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The IH NMR spectrum also revealed the presence of a one-proton
doublet at 85.11 (lH, d, J=8.1Hz), the corresponding carbon resonance
could be seen to occur at 8105.4 (d) in the HETCOR spectrum. This is
the correct chemical shift for hemiacetal and acetal carbons104 hence it
was concluded that this peak was due to a carbon atom joined to two
oxygen atoms. The COSY spectrum displayed coupling between the
doublet at 85.11 and a one-proton doublet at 82.71. Upon addition of
DzO to the sample, the resonance at 82.71 disappeared and the doublet at
85.11 collapsed into a singlet (spectrum h). This confirmed that the
resonance at 8105.4 (d) was due to a hemiacetal carbon atom. On the
basis of this observation, it was concluded that the doublet at 82.71 was
due to a hydroxy proton and the hemiacetal proton was coupled to this
hydroxy proton thereby appearing as a doublet. This was further
supported by the fact that the hydroxy proton resonance had no
corresponding carbon resonance in the HETCOR spectrum.
The carbon resonance at 876.1 (d) correlated with the one-proton
multiplet signal at 83.38 ascribable to H-3a. The H-3a signal appeared
as a multiplet due to splitting induced by the H-2 axial and equatorial
protons as well as the hydroxy proton. This was confirmed in the COSY
spectrum by observing the H-3 proton coupled to a one-proton doublet
signal at 83.75 which collapsed upon addition of DzO (spectrum 3h).
The H-3u signal was also coupled to a multiplet at 81.65 ascribable to
2H-2. This signal correlated with a carbon resonance at 823.1 (t). H-3
was assumed to be a orientated with a p-substituted hydroxy group as
with compounds 1 and 2 due to the parent compound of cucurbitacins
[63] having a p-substituted hydroxy group. The resonance at 82.24 (lH,
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t, J-9.19Hz) was observed to have a carbon resonance at 840.6 (d) and
was ascribable to H-10. The COSY spectrum also revealed coupling
between H-10 and a multiplet signal at 81.41 ascribable to 2H-1. This
signal correlated with a carbon resonance at 817.3 (t) in the HETCOR
spectrum.
Hemiacetals are products of addition of alcohols to aldehydes and since
compounds 1 and 2 each possess an aldehyde group attached to C-9, it
was appropriate to attach the hemiacetal carbon to C-9 as well, and the
ether linkage between C-19 and C-5. The C-19 signal resonated at
8105.4 (d) and C-5 at 886.6 (s) in the 13C NMR spectrum. The
5,9-hemiacetal nng was J3-substituted following cucurbitacin
stereochemistry. Furthennore, there was no NOE observed between
H-19 and H-8 (spectrum 3i) suggesting that this compound was the
(R)-epimer.
The proton and carbon spectra displayed a few minor peaks which were
initially attributed to an impurity, however now that the presence of a
hemiacetal ring has been confmned, the minor peaks could be attributed
to the (S)-epimer. The hemiacetal ring opens and closes in solution and
an equilibrium is eventually established. This phenomenon makes it
impossible to purify a single epimer, nevertheless the most stable epimer
is always present in larger quantities. As the two epimers were present
in different concentrations, it was possible to select the resonances
corresponding to the major epimer106 .
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The singlet at 83.13 (3H) was due to a methoxy group and this correlated
with a quartet at 850.3 in the HETCOR spectrum. The methoxy group
was placed at C-25 since jt was established that H-19 was coupled to a
hydroxy proton. The resonance for C-25 occured at 874.9 (s).
The IH NMR spectrum also indicated the presence of seven methyl
groups as deduced from the integrated signals. The methyl resonances at
80.83, 0.85, 0.87, 0.89 and 81.19 correlated with carbon resonances at
814.7 (q), 18.7 (q), 20.5 (q), 23.9 (q) and 819.7 (q). The signal at 81.23
(6H, s) correlated with resonances at 826.2 (q) and 25.8 (q) ascribable to
C-26 and C-27 respectively. From the HETCOR it was observed that
C-26 resonated further downfield than C-27 due to the influence ofH-24.
The rest of the peak assignments were made accordingly with
comparison with those of compounds 1 and 2, and are listed in tables 4
and 6.
Acetylation of compound 3 [102] with acetic anhydride/pyridine at room
temperature yielded two colourless amorphous compounds [102a] and
[102b]. The IH NMR spectra of these two products (spectrum 3j and 3k)
indicated that these were the two isomers of compound 3 acetate,
compound 3 being isomeric at C-19. Both these spectra displayed a
resonance at 82.08 (3H, s) indicating monoacetate formation. The H-3
resonances in both the spectra were unaffected, indicating that C-3
hydroxy group did not acetylate. A simple Dreiding model made it clear
as to why the C-3 hydroxy group was unaffected. The model indicated
that the 5,19-p-epoxy ring and the C-3 p-substituted hydroxy group were
in close proximity to each other. A hydrogen bond could exist between
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the C-3 hydroxy group and the ether oxygen thereby preventing the C-3
hydroxy group from acetylating. In spectrum 3j and 3k, the H-19
doublets had shifted downfield and appeared as singlets at 85.99
superimposed on the H-6 doublet and 85.82 respectively due to
deshielding induced by the acetate carbonyl groups. The two epimers
were now separable since, upon acetylation, the hemiacetal ring becomes
fixed making it unable to open and close in solution. The two epimers
thus displayed different retention times on column chromatography.
HO
[102a] and [102b]
An attempt was made to convert the hemiacetal ring into a five
membered ring lactone by oxidation. Due to the sensitivity of
hemiacetals towards acids, the lones' oxidation procedure was not
followed. Instead a more gentle procedure known as Sarett's oxidation105
was followed.
Treatment of compound 3 [102] with pyridine-Cr03 complex yielded a
colourless crystalline material [102c]. The IH NMR spectrum (spectrum
31) revealed that the doublets at 85.11 and 82.71 had disappeared.
Furthermore, the H-3u multiplet and the doublet at 83.75 due to the
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hydroxy proton had also disappeared. The l3C~ spectrum (spectrum
3m) revealed the loss of the hemiacetal carbon resonance at 8105.4 (d)
and the appearance of a lactone carbonyl carbon reson~ce at 8181.0.
The carbon resonance ascribed to C-3 at 876.l(d) had also disappeared.
The carbon resonance ascribable to the keto group was not distinguished
due to the low concentration of the sample however the lH~
spectrum provided confirmation of the presence of the C-3 keto group.
This confirmation was obtained by the appearance of a triplet of doublets
at 82.71 attributable to the axial C-2 proton, the chemical shift and
splitting pattern of which is characteristic of the proton when a keto
group is present at C_3 106 •
o
[102c]
Compound 3 was identified as 5,19-epoxy-19(R)-hydroxy-25-methoxy-
5J3-cucurbita-6,23-diene-3J3-01 [102J and has not been isolated
previously.
71
3.2.2. Compound 4 [103]
HO
[103]
High resolution mass spectroscopy (spectrum 4a) indicated a molecular
mass of 426.3498 g.mol-I correct for the molecular formula C2JI4602.
However, the IH and BC NMR spectra indicated that this compound was
similar to compound 3 suggesting the molecular ion may have been too
weak to be detected. Examination of the BC NMR spectrum revealed
the presence of 30 carbon atoms. As seen for compound 3 the loss of
CH20 2 occurs quite readily to give a formula of C2JI4602. Hence the
correct molecular formula was suggested be C30H4S04. The peak at m/z
426 may have been due to the loss of the hemiacetal fragment CH20 2
(46).
The infrared spectrum (spectrum 4b) displayed a broad band at 3365
cm-I due to O-H stretching vibrations. The bands at 2945 cm-I and 2877
cm-I indicated the presence of alkyl groups and the band at 1377 cm-I
indicated that methyl groups were present. The band at 1082 cm-I was·
due to C-O stretching vibrations while the presence of unsaturation was
indicated by a band at 1651 cm-I. The band at 1116 cm-I indicated that
an ether linkage was present.
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The IH NMR spectrum (spectrum 4c) was similar to that of compound 3
except for the absence of the methoxy group proton signal at 83.13 (3H,
s) which was placed C-25 in the previous compound. There were no
downfield shifted methyl group proton signals thereby ruling out the
possibility of a ~24,25 double bond.
The l3C NMR spectrum (spectrum 4d) again showed the sample was a
mixture but resonances due to the 30 carbon atoms of the major epimer
could be identified. The DEPT spectrum (spectrum 4e) revealed the
presence of seven quartets, seven triplets and ten doublets. The
remaining six carbon signals were assigned as singlets. The resonances
at 8139.6 (d), 132.7 (d), 132.4 (d) and 8125.2 (d), indicated that two
disubstituted double bonds were present while those at 8105.4 (d), 86.6
(s), 76.0 (s) and 870.7 (s) were due to oxygen-bearing carbons.
As in compound 3 proton resonances at 86.08 (lH, dd) and 85.66 (lH,
dd) were assigned to H-6 and H-7 respectively. H-6 was split into a
doublet by H-7 (J6,7=9.78Hz) and thereafter further split by long range
coupling to H-8 (J6,g=2.30Hz) resulting in a double doublet. H-7 was
also split into a doublet by H-6 followed by further splitting by H-8
resulting in a double doublet (J6,7=9,78Hz; J7,g=3.72Hz). A multiplet at
81.78 ascribable to 2H-22 as in compound 3 was seen coupled in the
COSY spectrum (spectrum 4f) to a multiplet at 85.58 integrated to two
protons. On this basis, it was deduced that the resonance at 85.58 was
due to H-23 and H-24 with the signals superimposed.
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The doublet at 85.10 (J=7.80Hz) was characteristic of a hemiacetal
proton being coupled to the hydroxy group proton. This was confirmed
in the COSY spectrum by observing the hemiacetal proton resonance
coupled to a doublet at 82.62 which in the proton spectrum disappeared
upon addition of D20 (spectrum 4g) and thereby collapsing the
hemiacetal doublet signal into a singlet. Another doublet at 83.74 also
disappeared on addition of D20 and this signal was initially seen coupled
to H-3a which occured as a multiplet at 83.40.
The l3C NMR spectrum displayed a carbon resonance at 886.6 (s) as in
compound 3 indicating that this oxygen bearing carbon was located at
C-5. Hence the ether linkage was established between C-5 and the
hemiacetal carbon (C-19). Furthermore H-6 was only seen to be coupled
to H-7 hence the singlet at 886.6 was assigned to C-5.
The resonances ascribable to 3H-26 and 3H-27 both occured at 81.29 as
a singlet as in compound 3 thereby ruling out the possibility of a
hydrogen or double bond at C-25. C-25 was therefore established as an
oxygen bearing carbon that resonated at 870.7 (s). Since the proton and
carbon spectra lacked evidence of a methoxy group, it was appropriate to
replace the methoxy group in the previous compound with a tertiary
hydroxy group.
The rest of the carbon and proton resonances were in agreement with
those of compound 3 and are listed in tables 4 and 6 respectively. Due
to the similarities of these spectra with those of compound 3, it was not
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considered necessary to obtain a HETCOR spectrum. As in Compound
3, this compound was assumed to be the (R)-epimer.
Acetylation of compound 4 yielded two compounds [103a] and [103b]
as monoacetates (spectra 4h and 4j) as observed by the single acetate
methyl group proton resonances in both spectra. This was expected
since upon acetylation the hemiacetal ring became fixed and the two
epimers were separable. It was observed as before that H-3 had not
shifted downfield however the signal due to the hemiacetal proton had
shifted to 85.80 and 85.98 respectively in spectra 4f and 4g and the H-19
doublets had collapsed into singlets. Furthermore, the doublet at 82.62
due to the hydroxy group had also disappeared. Based on the evidence
obtained, it can be concluded that hydroxy group at C-19 acetylated
whereas the C-3 J3-substituted hydroxy group did not acetylate due to
hydrogen bonding between C-3 OH and the ether oxygen. This was seen
for compound 3 when a Dreiding model was built to explain the
phenomenon. BC N1v1R spectra for compounds [103a] and [103b]
(spectra 4i and 4k) were obtained in order to distinguish between the two
epimers and a model was built to try and account for the small
differences in the IH N1v1R spectra however no logical conclusions could




carbonyl carbon occured at 8170 (s) but the corresponding peak in
[103a] could not be discerned due to the small amount of sample
available.
Treatment of compound 4 [103] with pyridine-Cr03 complex yielded a
colourless material [103c]. The IH NMR spectrum (spectrum 41)
revealed that the doublets at 85.11 and 82.71 had disappeared.
Furthermore, the H-3u multiplet and the doublet at 83.75 due to the
hydroxy proton had also disappeared. The appearance of a triplet of
doublets at 82.71 attributable to the axial C-2 proton was noted, the
chemical shift and splitting pattern of which is characteristic of the
proton when a keto group is present at C_3 106 . All this suggested that
compound [103] had been oxidised. The infrared spectrum (spectrum
4m) displayed characteristic absorption bands at 1749 cm- l due to the
stretching vibrations of a lactone carbonyl and at 1726cm-1 indicating the
presence of a saturated ketone. A l3C NMR spectrum could not be




Compound 4 has been identified as 5, 19-epoxy-19(R),25-dihydroxy-5~­
cucurbita-6,23-diene-3~-01 and is the second novel compound to be
isolated in this work from this plant.
76
3.2.3. Compound 5 [104]
[104]
This compound was isolated in very small quantities and as a result, .
much caution was exercised during final purification. A Pasteur pipette
packed with silica gel was used as a mini column through which the
compound was passed.
High resolution mass spectroscopy indicated the compound had a molar
mass of 486.3725 g.mol-1 (calculated 486.3709 g.mol-1) correct for the
molecular formula C31Hso04' The mass spectrum (spectrum Sa)
displayed peaks at m/z 426 (M+-C2H40 2) and 408 (M+-C2H40 2-H20). A
proposed fragmentation scheme for the molecule is illustrated in Scheme

















Scheme 16. Proposed fragmentation of Compound 5
All structures were supported by high resolution mass measurements
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The infrared spectrum (spectrum 5b) displayed strong absorption bands
at 3499 cm- l and 3456 cm- l due to OH stretching vibrations. The minor
band at 3028 cm- l together with the band at 1651 cm- l indicated
unsaturation in the molecule. The prominent bands at 2951 cm-
l
and
2877 cm- l were due to alkyl groups and this was confirmed by the band
at 1460 cm-I. The sharp band at 1377 cm-I indicated the presence of
methyl groups. The bands at 1157 cm-I and 1082 cm- l were due to C-O
stretching vibrations in alcohol groups while the asymmetric C-O-C
stretching vibration at 1114 cm- l suggested that an ether linkage was
present.
The IH NMR spectrum (spectrum 5c) displayed resonances at 86.00 (lH,
dd, J67=9.78Hz, J68=2.30Hz) and 5.50 (IH, dd, J67=9.78Hz," ,
J7,8=3.72Hz), as in compounds 3 and 4, ascribable to H-6 and H-7
respectively. A broad resonance at 85.57 integrated to two protons and
as with compound 4, this signal was ascribed to superimposed H-23 and
H-24 resonances.
The BC NMR spectrum (spectrum 5d) displayed strong resonances for
31 carbons. The DEPT spectrum (spectrum 5e) indicated eight quartets,
seven triplets and ten doublets. The remaining six resonances were
assigned as singlets. The carbon spectrum indicated the presence of four
alkene carbons at 8139.5 (d), 133.0 (d), 130.5 (d) and 8125.3 (d), five
oxygen-bearing carbons at 8114.7 (d), 85.1 (s), 76.2 (d), 70.7 (s) and
857.3 (q) and four quaternary carbons at 848.9 (s), 47.9 (s), 45.1 (s) and
837.1 (s). The fact that the alkene carbon resonances were all doublets
indicated that the two double bonds were disubstituted.
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The resonances at 8133.0 (d) and 130.5 (d), correlated with proton
resonances at 86.00 and 5.50 respectively in the HETCOR spectrum
(spectrum 5f) and were thus ascribed to C-6 and C-7 respectively. The
resonances 8139.5 (d) and 125.3 (d) corresponded to the superimposed
H-23 and H-24 signals at 85.57 and were assigned to C-23 and C-24.
Upon comparison of these resonances with those of compound 4, the
signal at 8139.5 (d) was assigned to C-24 and that at 8125.3 (d),
assigned to C-23 ..
The carbon spectrum also displayed a signal at 8114.7 (d) as with
compounds 3 and 4. This carbon signal correlated with a proton
resonance at 84.40 (1H, s) in the HETCOR spectrum and was assigned
to C-19. Unlike compounds 3 and 4, H-19 resonated as a singlet
suggesting that there was no hydroxy group at C-19.
The IH NMR spectrum displayed a strong singlet at 83.37 (3H)
characteristic of methoxy group protons. This signal corresponded with
a carbon resonance at 857.3 (q) in the HETCOR spectrum. The COSY
spectrum (spectrum 5g) revealed long range coupling between H-19 and
the methoxy group protons indicating that the methoxy group had
replaced the hydroxy group at C-19 as opposed to compounds 3 and 4.
These findings lead to the conclusion that compound 5 was an acetal.
The oxygen bearing carbon resonance at 885.1 (s) was assigned to C-5
and as with the previous two compounds, the carbon atom attached to
two oxygen atoms occured at C-19.
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The C-3 signal occured at 876.2 (d) and correlated with a broad singlet at
83.41 ascribed to H-3u. The COSY spectrum indicated coupling
between H-3u and a doublet-at 83.70 which collapsed upon addition of
D20 to the sample (spectrum 5h). This indicated that the resonance at
83.70 (d) was due to the C-3~ hydroxy proton. The hydroxy group was
assumed to be ~-substituted as in compound 3 and 4.
In the carbon spectrum, the singlet at 870.7 was assigned to C-25
bearing a tertiary hydroxy group as in compound 4.
The COSY spectrum displayed coupling between H-6 and H-7
resonances. The H-6 signal was also long-range coupled to a broad
singlet at 82.13 (lH) which correlated with a carbon resonance at 849.8
(d). This singlet in the proton spectrum was assigned to H-8 for similar
reasons as discussed for the previous two compounds. The sharp signal
at 81.29 (6H) correlated with carbon signals at 830.0 (q) and 829.9 (q)
which were ascribed to C-26 and C-27 respectively.
The remainder of the peaks were assigned in a similar manner to those of
compounds 3 and 4. The assignments were in good agreement with the
previous two compounds and are detailed in tables 4 and 6.
The proton and carbon spectra displayed minor resonances that were due
to the (S)-epimer present in small quantities as explained for compound
3.
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The standard acetylation procedure was followed but from the proton
spectrum (spectrum 5i), it was observed that H-3 signal did not shift
downfield as expected and no acetate methyl group proton signal
appeared. Hence it was concluded that the C-3 hydroxy group did not
acetylate due to the proposed hydrogen bonding between the C-3P
hydroxy group and the ether oxygen between C-5 and C-19. The
hydroxy group at C-25 did not acetylate under the reaction conditions.
Compound 5 was identified as 5,19-epoxy-19(R)-methoxy-25-hydroxy-
5p-cucurbita-6,23-diene-3p-ol and was assigned structure [104].
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3.2.5. Compound 6 [105]
[105]
Compound 6 had a mass of 470.3409 g.mol-I consistent with a molecular
formula C31Hso03. The mass spectrum (spectrum 6a) displayed peaks at
m/z 455 (M+-CH3), 440 (M+-CHzO) and 422 (M+-CHzO-HzO). The loss
of water indicated the presence of a hydroxy group. The fragmentation
profile was similar to that observed for the previous compounds
indicating structural similarities in the triterpene nucleus.
Infrared analysis (spectrum 6b) showed an absorption band at 3472 cm-I
indicating the presence of a hydoxy group. The bands at 3020 cm-I and
1683 cm-I were indicative of unsaturation in the molecule. The bands at
2943 cm-I and 2883 cm-I are due to alkyl groups, while the presence of
methyl groups was indicated by the sharp band at 1379 cm-I. The
infrared spectrum also indicated the asymmetric C-O-C stretching
vibration at 1138 cm-I suggesting that an ether linkage was present.
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The IH N1\1R spectrum (spectrum 6c) had four distinctive signals at
86.00 (lH, dd, J6,7=9.78Hz; J6,g=2.30Hz, H-6), 85.60 (lH, dd,
J7,g=3.72Hz; J6,7=9.78Hz, H-7), 85.47 (IH, m, H-23), 85.40 (IH, s, H-24)
indicating the presence of f16,7 and f123 ,24 double bonds.
The l3C N1\1R spectrum (spectrum 6d) displayed resonances for 31
carbons, eight of which were quartets, eight were triplets and nine were
doublets as indicated by the DEPT spectrum (spectrum 6e). The
remaining six carbon resonances were assigned as singlets. Unlike the
carbon spectra of the previous compounds, this spectrum showed no
hemiacetal carbon resonance. Instead, there was a signal at 879.8 (t)
which correlated with proton resonances at 83.65 and 83.49 in the
HETCOR spectrum (spectrum 6t). This indicated that the protons were
non-equivalent and evidence of geminal coupling was inferred from the
fact that both these protons resonated as doublets (Jgem=8.40Hz) and
were also seen coupled in the COSY spectrum (spectrum 6g).
The COSY spectrum also displayed coupling between H-6 and H-7 as
well as between H-23 and H-24. The corresponding carbon resonances
of these protons occured at 8131.8 (d), 131.5 (d), 128.3 (d) and 8136.8
(d) respectively. The H-23 multiplet was also coupled to a multiplet at
81.75 which correlated with a carbon resonance at 827.3 (t) ascribable to
C-22. The carbon resonance at 876.1 (d), typical of C-3, correlated with
a broad resonance at 83.31 (IH, W1/2=6.8Hz) ascribable to H-3a
indicating the presence of a f3-substituted hydroxy group. The COSY
spectrum revealed coupling between H-3 and a doublet at 83.97. This
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doublet disappeared on addition of D20 (spectrum 7g) and was hence
ascribed to the C-3 hydroxy group.
The resonance at 83.13 (3H, s), corresponding to a carbon signal at
850.3 (q), indicated that a methoxy group was present. On comparison
of the carbon spectrum with that of compound 3, it was logical to place
the methoxy group at C-25 since the chemical shift for this carbon was
identical in both compounds. Thus far the following structural features
were identified:
a) the presence of a C-3 J3-substituted hydroxy group,
b) the presence of /16,7 and /123,24 double bonds and
c) a C-25 methoxy group
No evidence of a hemiacetal ring was observed. However, the IR
spectrum did indicate the presence of an ether linkage. It was
appropriate to place this ether linkage between C-5 and C-I9 as in the
case of the previous compounds. The triplet at 879.8 was hence
assigned to C-19.
This compound was previously isolated from immature fruits of
Momordica charantia L. as the glycosides, momordicosides FI [88] and
G [90]90. The aglycone was obtained from enzymatic hydrolysis using
crude hesperidinase90. The reported NMR data of the aglycone were in
good agreement with the data reported for our compound, indicating that
the structure was correct.
Hence compound 6 was identified as 5,I9-epoxy-25-methoxy-5J3-
cucurbita-6,23-diene-3J3-o1and assigned structure [105].
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3.2.5. Compound 7 [106]
HO
[106]
High resolution mass spectroscopy indicated that the compound had a
molar mass of 500.3865 g.mol-1, consistent with a molecular formula
C32Hs20 4• The mass spectrum (spectrum 7a) displayed peaks at m/z 440
(M+-C2H40 Z), 375, 309,172 and 109.
The infrared spectrum (spectrum 7b) displayed a band at 3516 cm-1 due
to OH stretching vibrations. The strong bands at 2926 cm-1 and 2876
cm-1 indicated the presence of alkyl groups while the complexity of
bands between 1460 cm-1 and 1377 cm-1 confirmed the presence of
methyl groups. The band at 1114 cm-' was due to the asymmetric C-O-C
stretching vibration indicating the presence of an ether.
The 1H N1v1R spectrum displayed proton resonances at 83.37 (3H, s) and
83.13 (3H, s) characteristic of two methoxy groups, a broad signal at
83.48, ascribable to H..3u, that was slightly superimposed by the
methoxy group proton signal and a sharp resonance at 84.40 (lH, s),
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characteristic of a hemiacetal proton as in compound 5. The H-6 signal
at 86.07 (lH, dd, J6,7=9.78Hz; J6,s=2.30Hz) and the H-24 signal were
also quite distinct. However, a -multiplet integrating to two protons
occurred at 85.50 (m). The COSY spectrum (spectrum 7d) revealed that
both H-6 and H-24 were coupled to this multiplet. It was therefore
concluded that this resonance was due to the superimposed resonances
of H-7 and H-23. Furthermore, coupling was also noticed between H-22
(81.72, m) and the H-23 signal.
A total 32 carbon signals was evident in the carbon spectrum (spectrum
7e), the multiplicities (spectrum 7f) and chemical shifts of which were
similar to those observed in compound 3. However, a second quartet was
observed at 857.3 (q). This chemical shift was similar to that observed
for the methoxy group carbon in compound 5, suggesting that the second
methoxy group was attached to the hemiacetal group carbon.
The COSY spectrum also revealed coupling between H-3a and the
p-substituted hydroxy group, a common feature in the compounds
discussed. There was also long range coupling observed between H-6
and a broad signal at 82.24 ascribable to H-8
There was no HETCOR spectrum obtained for this compound since the
above data and reasoning indicated that this compound was the
19-methoxy analogue of compound 3.
87
The two epimers of this compound were previously isolated from the
leaves and vines of Momordica charantia L. presumably as the natural
acetates91 , but no nmr peak assignments were given by the authors.
This compound was identified as 5,19-epoxy-19(R),25-dimethoxy-




4.1.1. lH and 13e NMR spectroscopy
All IH N1v1R, 13C N1v1R and 2-dimensional N1v1R spectra were recorded
at room temperature on a Varian Gemini 300 MHz spectrometer. The
solvent used was deuteriochloroform (CDCI3), and all 8 values were
relative to TMS. A singlet at 81.52 occured in the proton spectra for
most of the compounds and was due to a solvent impurity which is
indicated with an X in the relevant spectra.
4.1.2. Infrared Spectroscopy
The samples were prepared in KBr discs and infrared spectra recorded
on a 2020 Galaxy series FTIR spectrophotometer coupled with a Spectra
Tech Advanced Analytical Microscope. The data was acquired using the
Mattson software (copyrighted 1989).
4.1.3. High Resolution Mass spectrometry
High resolution mass spectra were recorded at the Cape Technikon on a
Kratos High Resolution MS 9/50 mass spectrometer by Dr P. Boshoff.
The voltage of the ion source was maintained at 70 eV.
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4.2. Melting point
Melting points were detennined on a Kofler micro hotstage melting point
apparatus and are uncorrected.
4.3. Optical rotations
Optical rotations were recorded at 25,5 QC in chlorofonn solution on a
Perkin-Elmer 241 polarimeter. A sodium lamp was used at a wavelength




Column chromatography was perfonned repeatedly in order to separate
and purify the compounds present in the extracts. The length and
diameter of the columns as well as the particle size of the stationary
phase had to be varied in order to optimise resolution of the compounds.
Initially, use was made of a glass column packed with silica gel 60
(0,2-0,5 mm particle size, 35-20 mesh ASTM, Merck Art 7734), with
gravity elution. This was followed by the use of gravity columns packed
with silica gel 60 (0,040-0,053 mm particle size, 230-400 mesh ASTM,
Merck Art.9385). In certain cases, flash chromatography was found
useful for the speedy separation of mixtures. The latter technique
involved the use of pressure in order to elute the various fractions from
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the column. The flow rate was maintained at approximately 60 ml/min
for flash chromatography.
4.4.2. Thin Layer Chromatography (TLC)
Thin layer chromatography was conducted on the crude extracts and the
VarIOUS fractions collected, using pre-coated 0,2 mm thick
aluminium-backed silica gel 60 (Merck Art 5553) TLC plate. The spots
on the plates were visualised by spraying with a reagent comprising
anisaldehyde , sulphuric acid (cone) and methanol in the ratio 1,25 : 2,5 :
96,25. Coloured spots were observed after heating the plates with a
heatgun.
4.5. Liebermann-Burchard test
This test was conducted for the identification of compounds containing a
triterpene nucleus. The Libermann-Burchard reagent was prepared by
adding 9.5 ml acetic anhydride to 0.5 ml sulphuric acid (cone). An equal
volume of this reagent was then added to a solution of the compound
under investigation, in chloroform. The formation of an intense blue
colour confirmed the presence of a triterpene.
4.6. Tollen's test
This test was performed to confirm the presence of an aldehyde. One
drop of 10% aqueous sodium hydroxide was added to 1 ml of 5%
aqueous silver nitrate in a test tube. The tube was shaken followed by
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the addition of a dilute solution of ammonium hydroxide with shaking
until the precipitate of silver hydroxide just dissolved. Approximately 5
mg of the compound under investigation was added to the reagent and
the solution heated for 5 min in a water bath. The formation of a silver
mIrror on the walls of the test tube confirmed the presence of an
aldehyde.
4.7. Preparation and extraction of plant material
Fresh plant material of Momordica foetida Schum. & Sond. was
purchased at the Umlazi herbal market during December 1993 and its
identification authenticated by comparison with a reference specimen at
the Natal Herbarium.
The leaves were carefully separated from the vines and air dried for one
week. The 'leaves were thereafter ground to powder in a coffee grinder.
The powdered leaves (440 grams) were then extracted in a soxhlet
apparatus by refluxing successively with hexane, cWoroform and
methanol. The hexane and methanol extracts were reserved for possible
future investigations. The chloroform extract was concentrated under
vacuum and thereafter extracted with 1M NaOH. This resulted in an
organic and an aqueous phase. The organic phase, containing extract A,
afforded two compounds viz. compounds 1 and 2.
The basic aqueous fraction was neutralised to litmus paper with 6M Hel
and re-extracted with chloroform (3 x 250 ml). The combined extracts
were dried over Na2S04, filtered and concentrated under vacuum. This
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extract, extract B (1.39 grams), afforded five compounds viz. compounds
3,4,5,6, and 7. The extraction procedure is outlined in Scheme 17.
Fresh plant material
Ilealoes separated ITom \lines
f )
vines leaves






with lM NaOH -methanol extract
Organic layer (Extract A) Basic aqueous layer
j",",~I','" with 6M Ha
Neutral aqueous layer + insoluble material
):::: "''',,,'''" wtth ,ho""",,
Organic layer (Extract B1 Neutral aqueous layer
Scheme 17. Schematic layout of extraction procedure
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4.8 Acetylation of compounds 1, 2, 3, 4, 5 and 6
A quantity of 2 mg of each compound was each dissolved in 1 ml
pyridine and the solution gently wanned on a steam bath. A 1 ml aliquot
of acetic anhydride was then added to each solution, which was stirred
and left to stand overnight at room temperature. Thereafter 10 ml
methanol was added to hydrolyse the residual anhydride. Two 10 ml
portions of toluene was then' added to the mixture and subsequently
removed under reduced pressure in order to remove traces of pyridine.
The residual toluene was removed under reduced pressure by the
addition of two 10 ml aliquots of methanol.
4.9 Oxidation of compounds 3 and 4
The compounds were oxidised using the chromium trioxide-pyridine
complex (Sarret oxidationyo5.
The complex was prepared by gently adding 1 g chromic anhydride to, 10
ml reagent grade pyridine. The first phase consisted of slow dissolution
of the anhydride without formation of the complex, however, after about
one-third of the chromic anhydride had been added and mostly
dissolved, the yellow complex began to precipitate. At the end of the
addition a slurry of the complex remained.
A quantity of 2 mg of compounds 3 and 4 in 2 ml pyridine were each
added to 2 ml'quantities of the slurry. The reaction flask was stoppered,
94
the contents mixed thoroughly and allowed to stand at room temperature
overnight. The' reaction mixture was poured into water and extracted
with 3 x 50 ml portions of benzene-ether (1: 1). The organic layer was
concentrated under reduced pressure and the resulting product purified
by column chromatography.
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4.10. Extractives from Extract A
Column chromatography of extract A (5.39 grams) resulted m the
isolation of two compounds.
4.10.1. Compound 1 [92]
(3(3,7(3,23~-trihydroxy-cucurbita-5,24-diene-19-al)
Mobile phase: 50% chloroform, 50% ethyl acetate
Rr value: 0.25
Description: white amorphous powder
Yield: 70mg
Mass: [Mt at m/z 472.3551 (C30H4S04 requires 472.3552)
Mass Spectrum: (Spectrum 1a)
EIMS m/z 472, 454, 436, 426, 408, 389, 309
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IR spectrum: (Spectrum 1b)
Umax (KBr): 3404 cm-
1 (OH)
2947 cm-1 (-CH3, >CH2)
1709 cm-1 (CHO)
1666 cm-I (C=C)
1467 cm-1 (C-H deformations)
1379 cm-1 (>C(CH3)2)
Optical rotation: [a]D = +73.1° (CHC13, c 0.160) (lit. +81.3°)91
melting point: 123-125 °c (lit. 125-128 °C)91
IH NMR.: (300l\1Hz, Spectrum lc)
8 9.69 (lH, s, CHO), 5.87 (lH,d, J6,7=5.13 Hz, J6,IO=1.92Hz, H-6), 5.17
(lH, d, J24,23=5.17 Hz, H-24), 4.44 (lH, bt, J23,24=5.17Hz, H-23), 3.95
(lH, bs, W1/2=8.00Hz, H-7a), 3.54 (lH, b,W1/2=7.61Hz, H-3a), 2.52 (lH,
m, H-10), 2.07 (lH, m, H-17), 1.81 (2H, m, H-1), 1.75 (2H, m, H-2),
1.71 (lH, m, H-20), 1.68 (3H, s, 3H-27), 1.66 (3H, S, 3H-26), 1.65 (2H,
m, H-12), 1.61 (2H, m, H-22), 1.45 (2H, m, H-16), 1.38 (2H, m, H-15),
1.22, 1.03,0.96, 0.73, (each 3H, S, 4xCH3), 0.89 (3H, d, 3H-21).
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l3C NMR: (75MHz, Spectrum Id)
(Table 3 for assignments)
8 207.8 (d), 145.5 (s), 133.9 (s), 128.9 (d), 123.9 (d), 76.1 (d), 66.3 (d),
65.9 (d), 50.77 (d), 49.9 (s), 47.6 (s), 47.5 (d), 45.4 (s), 44.4 (t), 41.4 (s),
36.6 (d), 34.6 (t), 32.6 (d), 29.1 (t), 28.4 (t), 27.7 (t), 27.2 (q), 25.7 (q),
25.4 (q), 23.5 (t), 21.2 (t), 18.8 (q), 18.1 (q), 17.9 (q), 14.8 (q).
4.10.1.1. Acetylation of compound 1
A quantity of 2mg of compound I was dissolved in pyridine and the
acetylation procedure carried out as described in 4.8. to yield a
colourless amorphous substance [92a].
IH NMR data of [92a] (300l\1Hz, spectrum lj)
89.80 (IH, s, CHO), 5.84 (lH, dd, J6,7=5.13Hz, J6,1O=1.92Hz, H-6), 5.57
(lH, H-23), 5.17 (IH, d, J Z4,Z3=5.40Hz, H-24), 5.07 (IH, d, H-7a), 4.79
(IH, bs, Wl/z=6.8Hz, H-3a), 2.52 (IH, m, H-I0), 1.99, 1.99, 1.97 (3H, s,
3xO-C-OCH3), 1.70 (3H, s, 3H-27), 1.67 (3H, s, 3H-26), 1.23, 1.09,
0.83,0.78 (each 3H, s, 4xCH3), 0.92 (3H, d, J=5.7Hz, 3H-21).
4.10.2. Compound 2 [93]
(313,713,25-trihydroxycucurbita-5,23-dien-19-al)




Mass: [Mr at m/z 472.3552 (C30H4s04 requires 472.3552)
Mass Spectrum: (Spectrum 2a)
EillS m/z 472,454, 436, 426, 408, 389, 309
IR spectrum: (Spectrum 2b)
\)max (KBr): 3273 cm- l , 3431 cm-l (OH)
2955 cm-l (-CH3, >CH2)
1701 cm-l (CHO)
1465 cm-l (C-H defonnations)
1375 cm-l (>C(CH3)2)
1134 cm-l (C-O stretching)
melting point: 188-191 °c (lit 190-192 °C)9l
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IH NMR.: ",(300MHz, Spectrum 2c)
8 9.61 (IH, s, CHO), 5.87 (IH, dd, J6,7=5.13Hz; J6,1O=1.92Hz, H-6), 5.56
(2H; m, H-23; H-24), 3.95 (IH, bs, W1/2=8.00Hz, H-7a), 3.55 (lH, bs,
Wl/2=7.61Hz, H-3a), 2.52 (IH, m, H-I0), 1.82 (2H, m, H-l), 1.71 (2H,
m, H-2), 1.69 (2H, m, H-22), 1.43 (IH, m, H-20), 1.30 (2H, m, H-15),
1.29 (6H, s, 3H-26; 3H-27), 1.22, 1.03, 0.89, 0.87, 0.73 (each 3H, s,
5xCH3).
l3C NMR.: (75 MHz, Spectrum 2d)
(Table 3 for assignments)
8 207.8 (d), 145.5 (s), 139.6 (d), 125.1 (d), 123.9 (d), 76.1 (d), 70.7 (s),
66.3 (d), 49.9 (d), 49.9 (s), 47.5 (d), 47.5 (s), 45.3 (s), 41.4 (s), 39.0 (t),
36.6 (d), 36.1 (d), 34.7 (t), 29.9 (q), 29.8 (q), 28.9 (t), 28.4 (t), 27.4 (t),
27.2 (q), 25.3 (q), 23.5 (t), 21.2 (t), 18.7 (q), 17.9 (q), 14.9 (q).
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4.10.2.1. Acetylation of Compound 2
A quantity of 2mg of compound 2 was acetylated following. the
procedure outlined in 4.8. to yield a colourless amorphous substance
[93a].
IH Nl\1R data of [93a] (300MHz, Spectrum 2i)
8 9.81 (lH, s, CHO), 5.85 (IH, dd, J6,7=5.13Hz, J6,lO=1.92Hz, H-6), 5.56
(2H, m, H-23; H-24), 5.18 (IH, d, J6,7=5.13, H-7a), 4.80 (IH, bs,
Wl/z=7.2Hz, H-3a), 2.53 (IH, m, H-I0), 2.01, 2.00 (each 3H, s,
3xO-COCH3), 1.28 (6H, s, 3H-26, 3H-27), 1.13, 1.10, 0.84,0.78 (3H, s,
4xCH3), 0.87 (3H, d, J-6.0Hz, 3H-21).
101
4.11. Extractives from Extract B
Extract B (1.39 grams) was separated by means of column
chromatography and so obtained five compounds.
4.11.1. Compound 3 [102]
(5,19-epoxy-19(R)-hydroxy-25-methoxy-5~-cucurbita-6,23-diene-3 ~-ol)





Mass: [Mr at m/z 486.3725 (C3IHso04 requires 486.3709)
Mass Spectrum: (Spectrum 3a)
EIMS m/z 486,471,440,422,408,309,239, 109
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IR Spectrum: (Spectrum 3b)
U max (KBr): 3292 cm-
l (OH)
2949 cm-! (-CH3, >CH2)
1649 cm-! (C=C)
1375 cm-! (>C(CH3)2)
1080 cm-1 (C-O stretching)
Optical rotation: [a]D = -55.9° (CHCI3, c 0.102)
Melting point: 182-184°C (Recrystallised from a mixture of
hexane:diethyl ether (1 :2))
lH NMR.: (300:MHz, Spectrum 3c)
o 6.06 (lH, dd, J6,7=9.78Hz; J6,g=2.30Hz, H-6), 5.65 (lH, dd,
J7,g=3.72Hz; J6,7=9.78Hz, H-7), 5.42 (lH, m, H-23), 5.40 (lH, s, H-24),
5.11 (lH, d, J--7.98Hz, H-19), 3.75 (d, OH), 3.38 (lH, m, H-3), 3.13
(3H, s, OCH3), 2.82 (lH, bs, H-8), 2.71 (d, OH), 2.45 (lH, bt,J 9.19Hz,
H-10), 1.94 (2H, m, H-16), 1.82 (2H, m, H-l2), 1.76 (2H, m, H-22), 1.65
(2H, m,H-1), 1.40 (lH, m, H-17), 1.38 (2H, t, J-11.58Hz, H-15), 1.23
(6H, s, 3H-26; 3H-27), 1.19 (3H, s, 3H-21), 0.89, 0.87, 0.85, 0.83 (each
3H, s, 4xCH3).
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13C NMR: (75 MHz, Spectrum 3d)
(Table 4 for assignments)
8 136.8 (d), 132.7 (d), 132.4 (d), 128.3 (d), 105.4 (d), 86.6 (s), 76.1 (d),
74.9 (s), 50.3 (q), 49.9 (d), 48.5 (s), 48.0 (s), 45.1 (s), 41.4 (d), 40.6 (d),
39.4 (t), 37.2 (s), 36.1 (d), 33.5 (t), 30.5 (t), 27.9 (t), 27.1 (t), 26.2 (q),
25.8 (q), 20.5 (q), 23.1 (t), 23.9 (q), 19.7 (q), 18.7 (q), 17.3 (t), 14.7 (q).
4.11.1.1. Acetylation compound 3
A quantity of 2mg of compound 3 was acetylated in the usual manner to
yield the two epimers(102a] and (102b].
IH NMR data (300MHz, Spectrum 3k) Acetate 1
8 6.08 (IH, dd, J6,7=9.78Hz, J6,g=2.30Hz, H-6), 5.82 (IH, s, H-19), 5.53
(IH, dd, J7,g=3.72Hz, J6,7=9.78Hz, H-7), 5.48 (IH, m, H-23), 5.42 (IH, s,
H-24), 3.39 (IH, m, H-3a), 3.13 (3H, s, OCH3), 2.40 (lH, bs, H-I0),
2.07 (3H, S, O-C-OCH3), 1.23 (6H, s, 3H-26, 3H-27), 1.20 (3H, s,
3H-21), 0.89, 0.87, 0.85, 0.83 (each 3H, s, 4xCH3).
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IH NMR data (300MHz, Spectrum 3j) Acetate 2
_() 5.99 (2H, m, H-6, H-19), 5.65 (IH, dd, J=9.78Hz, H-7), 5.48 (IH, m,
H-23), 5.40 (IH, s, H-24), 3.46 (IH, m, H-3a), 3.13 (3H, s, OCH3), 2.80
(IH, bs, H-I0), 2.07 (3H, S, O-C-OCH3), 1.23 (6H, s, 3H-26, 3H-27),
1.20 (3H, s, 3H-21), 0.89, 0.87, 0.85, 0.83 (each 3H, s, 4xCH3)·
4.11.1.2. Oxidation of compound 3
A quantity of 2mg of the compound was oxidised following the
procedure outlined in 4.9. to yield [102c].
IH NMR data of [102c] (300MHz, Spectrum 31)
() 6.18 (IH, dd, J6,7=9.78Hz, J6,s=2.30Hz, H-6), 5.80 (lH, dd,
J7,s=3.72Hz, J6,7=9.78Hz, H-7), 5.48 (IH, m, H-23), 5.42 (IH, s, H-24),
3.13 (3H, s, OCH3), 2.71 (lH, td, H-2aJ, 1.24 (6H, s, 3H-26, 3H-27),
1.20, 1.17, 0.92, 0.91. 0.90 (each 3H, s, 5xCH3).
13C NMR data of [102c] (75MHz, Spectrum 3m)
() 180.7 (s), 137.0 (d), 134.3(d), 130.3 (d), 128.1 (d), 88.0 (s), 74.8 (s),
51.1 (d), 50.3 (q), 50.2 (s), 47.8 (s), 47.7 (s), 45.1 (d), 44.5 (d), 39.9 (t),
39.3 (s), 36.1 (d), 35.2 (t), 33.2 (t), 29.8 (t), 27.4 (t), 26.2 (q), 25.8 (q),
25.2 (q), 23.4 (t), 21.8 (q), 19.3 (q), 18.6 (q), 16.9 (t), 14.6 (q).
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4.11.2. Compound 4 [103]
(5,19-epoxy-19(R),25-dihydroxy-5B-cucurbita-6,23-diene-3B-ol)




Mass Spectrum: (Spectrum 4a)
EIMS m/z 426,408, 393, 365, 339, 309
IR Spectrum: (Spectrum 4b)
Umax (KBr): 3365 cm-I (OH)






1460 cm-I (C-H deformations)
1377 cm-I (>C(CH3)2)
1082 cm-I (C-O stretching)
Optical rotation: [a]D = -93.2° (CHCI3, c 0.278)
106
IH NMR: (300MHz, Spectrum 4c)
8 6.06 (lH, dd, J6,7=9.80Hz, J6,g=2.30Hz, H-6), 5.65 (lH, dd,
J6,7=9.80Hz, J7,8=3.72Hz, H-7), 5.58 (2H, m, H-23, H-24), 5.10 (lH, d,
J-7.80Hz, H-19), 3.40 (lH, m, H-3a), 2.82 (lH, m, H-8), 2.45 (lH, bt,
J-2.19Hz, H-10), 1.92 (2H, m, H-16), 1.78 (2H, m, H-22), 1.68 (2H, m,
H-2), 1.61 (2H, m, H-ll), 1.50 (lH, m, H~20), 1.47 (2H, m, H-1), 1.35
(2H, m, H-15), 1.30 (IH, m, H-17), 1.29 (6H, S, 3H-26, 3H-27), 1.20
(3H, d, J 5.70Hz, 3H-21), 0.87, 0.86, 0.85, 0.83 (each 3H, S, 4xCH3).
l3C NMR: (75MHz, Spectrum 4d)
(Table 4 for assignments)
8 139.6 (d), 132.7 (d), 132.4 (d), 125.2 (d), 105.4 (d), 86.6 (s), 76.0 (d),
70.7 (s), 50.0 (d), 48.5 (s), 48.0 (s), 45.1 (s), 41.4 (d), 40.6 (d), 39.1 (t),
38.0 (t), 36.2 (d), 33.5 (t), 30.5 (t), 30.0 (t), 29.8 (q), 27.9 (t), 27.1 (q),
23.9 (q), 23.1 (t), 20.4 (q), 19.7 (q), 18.6 (q), 17.3 (t), 14.7 (q).
4.11.2.1. Acetylation of compound 4
A quantity of 2mg of compound 4 was acetylated in the manner
described in 4.8 to yield two monoacetates [103a] and [103b] (Spectrum
4h and 4i).
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lH NMR data (300l\1Hz, Spectrum 4h) Acetate 1
8 6.06 (lH, dd, J6,7=9.78Hz, J6,s=2.30Hz, H-6), 5.63 (IH, m, H-7), 5.82
(lH, s, H-19), 5.58 (2H, m, H-23, H-24), 3.37 (IH, m, H-3a), 2.80 (IH,
m, H-8), 2.06 (3H, S, O-C-OCH3), 1.29 (6H, s, 3H-26, 3H-27), 1.20,
0.87, 0.86, 0.85, 0.83 (each 3H, s, 5xCH3).
lH NMR data (300l\1Hz, Spectrum 4i) Acetate 2
86.00 (2H, m, H-6, H-19), 5.63 (IH, dd, J6,7=9.80Hz, J7,s=3.72Hz, H-7),
5.58 (2H, m, H-23, H-24), 3.38 (IH, m, H-3a), 2.79 (lH, m, H-8), 2.45
(IH, m, H-I0), 2.09 (3H, S, O-C-OCH3), 1.29 (6H, s, 3H-26, 3H-27),
1.23, 1.18, 0.87, 0.85, 0.80 (each 3H, s, 5xCH3).
4.11.2.2. Oxidation of compound 4
A quantity of 2mg of the compound was oxidised following the
procedure outlined in 4.9. to yield [103c].
lH NMR data of [103c] (300l\1Hz, Spectrum 41)
8 6.18 (IH, dd, J6,7=9.78Hz, J6.s=2.30Hz, H-6), 5.78 (IH, dd,
J6,7=9.78Hz, J7,s=3.72Hz, H-7), 5.58 (2H, m, H-23, H-24), 2.71 (IH, td,
H-2aJ, 1.29 (6H, s, 3H-26, 3H-27), 1.20, 1.17, 0.92, 0.90, 0.88 (each 3H,
s,5xCH3)·
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4.9.3. Compound 5 [104]
(5,19-epoxy-19(R)-methoxy-25-hydroxy-5p-cucrbita-6,23-diene-3p-ol)









[Mr at m/z 486.3725 (C3IHso04 requires 486.3709)
Mass Spectrum: (Spectrum 5a)
EIMS mlz 486, 426, 408, 309, 281, 186, 95
IR Spectrum: (Spectrum 5b)
Umax (KBr): 3455 cm-
I (OH)
2951 cm-I (-CH3, >CHz)
1651 cm-I (C=C)
1460 cm-I (C-H deformations)
1377 cm-I (>C(CH3)2)
1157 cm-' (C-O stretching)
Optical rotation: [a]D = -52.8° (CHCI3, c 0.036)
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melting point: 102-104QC
IH Nl\1R.: (30011Hz, Spectrum 5c)
8 6.10 (lH, dd, J6,7=9.71Hz, J6•g=2.30Hz, H-6), 5.57 (2H, bs, H-23;
H-24), 5.50 (lH, dd, J6,7=9.71Hz, J7,g=3.72Hz, H-7), 4.40 (lH, s, H-19),
3.70 (d, OH), 3.41 (lH, bs, H-3a), 3.37 (3H, s, OCH3), 2.29 (lH, m,
H-10), 2.13 (lH, bs, H-8), 1.92 (2H, m, H-16), 1.72 (2H, m, H-22), 1.65
(2H, m, H-12), 1.57 (2H, m, H-2), 1.52 (2H, m, H-ll), 1.48 (lH, m,
H-20), 1.41 (lH, m, H-17), 1.39 (2H, m, H-15), 1.34 (2H, m, H-1), 1.29
(6H, s, 3H-26; 3H-27), 1.23 (3H, s, 3H-21), 0.88, 0.86, 0.83, 0.84 (each
3H, s, 4xCH3).
13C Nl\1R.: (75MHz, Spectrum 5d)
(Table 4 for assignments)
8 139.5 (d), 133.0 (d), 130.5 (d), 125.3 (d), 114.7 (d), 85.1 (s), 76.2 (d),
70.7 (s), 57.3 (q), 50.1 (d), 49.8 (d), 48.9 (s), 47.9 (s), 45.1 (s), 39.1 (t),
37.9 (d), 37.1 (s), 36.2 (d), 33.5 (t), 30.4 (t), 29.9 (q), 30.0 (q), 27.8 (t),
27.1 (t), 24.4 (q), 21.4 (t), 20.6 (q), 20.5 (q), 18.6 (q), 16.5 (t), 15.0 (q).
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4.9.4. Compound 6 [105]
(5,19-epoxy-25-methoxy-5~-cucurbita-6,23-diene-3~-ol)




Mass: [Mr at m/z 470.3632 (C3IHso03 requires 470.3409)
Mass Spectrum: (Spectrum 6a)
EIMS m/z 470, 455, 440, 422, 309
IR Spectrum: (Spectrum 6b)
Umax (KBr): 3472 cm-l (OH)
2943 cm-1 (-CH3, >CH2)
1446 cm-1 (C-H deformations)
1379 cm-1 (>C(CH3)2)
1080 cm-1 (C-O stretching)
Melting point: 139-141QC
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IH NMR.: (300rvlliz, Spectrum 6c)
8 6.00 (IH, dd, J6;7=9.78Hz, J6,g=2.30Hz, H-6), 5.60 (lH, dd,
J67=9.78Hz, J78=3.72Hz, H-7), 5.47 (IH, m, H-23), 5.40 (lH, s, H-24),, ,
3.65,3.49 (IH, dd, Jgem=8.40Hz, H-19), 3.31 (lH, m, H-3a), 3.13 (3H, s,
OMe), 2.32 (IH, m, H-8), 2.18 (lH, m, H-I0), 1.75 (2H, m, H-22), 1.61
(2H, m, H-2), 1.51 (2H, m, H-ll), 1.48 (lH, m, H-17), 1.32 (2H, m,
H-l), 1.31 (2H, m, H-15), 1.23 (6H, s, 3H-26, 3H-27), 1.18,0.89,0.87,
0.85, 0.83 (each 3H, s, 5xCH3).
l3C NMR.: (75 rvlliz, Spectrum 6d)
(Table 4 for assignments)
o 136.8 (d), 131.8 (d), 131.5 (d), 128.3 (d), 87.5 (s), 79.8 (t), 76.1 (d),
74.8 (s), 52.0 (d), 50.3 (q), 49.9 (d), 48.6 (s), 45.5 (s), 45.2 (s), 39.4 (t),
38.8 (d), 37.2 (s), 36.1 (d), 33.2 (t), 30.8 (t), 27.9 (t), 27.3 (t), 26.1 (q),
25.8 (q), 24.5 (q), 23.6 (t), 20.5 (q), 20.0 (q), 18.7 (q), 17.6 (t), 14.9 (q).
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4.9.5. Compound 7 [106]
(5,19-epoxy-19(R),25-dimethoxy-5J3-cucurbita-6,23-diene-3J3-01)




Mass: [Mt at m/z 500.3874 (C32Hs20 4 requires 500.3865)
Mass Spectrum: (Spectrum 7a)
EIMS m/z 500, 440, 375,309, 172, 109
IR Spectrum: (Spectrum 7b)
umax (KBr): 35 i 6 cm-1 (OH)
2926 cm-I, 2876 cm-l (-CH), >CH2)
1377 cm-1(C(CH3)2)
1109 cm- l (C-O-C stretching)
1070 cm-1 (C-O stretching)
Optical rotation: [a]D = -37.1° (CHCI3, c 0.054)
113
IH NMR: (300MHz, Spectrum 7c)
8 6.07 (lH, dd, J6,7=9.78Hz, J6,8=2.30Hz), 5.50 (lH, m, H-7), 5.45 (lH,
m, H-23), 5.40 (lH, s, H-24), 4.40 (lH, s, H-19), 3.37, 3.13 (each 3H, s,
2xOMe), 3.48 (lH, m, H-3a), 2.24 (lH, m, H-8), 2.15 (lH, m, H-10),
1.72 (2H, m, H-22), 1.59 (lH, m, H-20), 1.45 (2H, m, H-1), 1.23 (6H, s,
3H-26, 3H-27), 0.90, 0.88, 0.87, 0.86, 0.83 (3H, S, 5xCH3).
BC NMR: (75MHz, Spectrum 7e)
8 133.5 (d), 130.5 (d), 128.4 (d), 114.7 (d), 85.1 (s), 76.2 (d), 74.9 (s),
57.3 (q), 50.3 (q), 50.0 (d), 49.8 (d), 48.9 (s), 48.0 (s), 45.1 (s), 39.4 (t),
37.9 (d), 37.1 (s), 36.8 (d), 36.1 (d), 33.5 (t), 30.4 (t), 27.8 (t), 27.1 (t),
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Table 3. l3C NMR data for compounds 1 and 2 (75"MHz, CDCI3, TMS
as internal standard) All chemical shift values are expressed in ppm (0)
Carbon Compound Compound
number 1 2
1 27.7 (t) 27.4 (t)
2 28.4 (t) 28.4 (t)
3 76.1 (d) 76.1 (d)
4 41.4 (s) 41.4 (s)
5 145.5 (s) 145.5(s)
6 123.9 (d) 123.9 (d)
7 66.2 (d) 66.3 (d)
8 50.8 (d) 49.9 (d)
9 49.9 (s) 49.9 (s)
10 36.6 (d) 36.6 (d)
11 23.5 (t) 23.5 (t)
12 29.1 (t) 28.9 (t)
13 45.4 (s) 45.3 (s)
14 47.6(s) 47.5 (s)
15 34.6 (t) 34.7 (t)
16 21.2 (t) 21.2 (t)
17 47.4 (d) 47.5 (d)
18 14.81 (q) 14.91 (q)
19 207.8 (d) 207.8 (d)
20 32.6 (d) 36.1 (d)
21 18.8 (q) 18.7 (q)
22 44.4 (t) 39.0 (t)
23 65.9 (d) 125.1 II (d)
24 128.9 (d) 139.6II (d)
25 133.9 (s) 70.7 (s)
26 18.1 (q) 29.8 (q)
27 25.7 (q) 29.9 (q)
28 25.31 (q) 27.l I (q)
29 27.21 (q) 25.31 (q)
30 17.91 (q) 17.91 (q)
NOTE: Assignments denoted I and IT within any vertical column can be
interchanged.
Table 4. l3C NMR data for compounds 3, 4, 5, 6 and 7 (75:rvtHz, CDCI3,
TMS as internal standard) All chemical shift values are expressed
in ppm (8)
116
Carbon Compound Compound Compound Compound Compound
number 3 4 5 6 7
1 17.3(t) 17.3(t) 16.5 (t) 17.6 (t) 16.5 (t)
2 23.1 (t) 23.1 (t) 21.4 (t) 23.6 (t) 21.4 (t)
3 76.1 (d) 76.0 (d) 76.2 (d) 76.1 (d) 76.2 (d)
4 45.1 (s) 45.1 (s) 45.1 (s) 45.2 (s) 45.1 (s)
5 86.6 (s) 86.6 (s) 85.1 (s) 87.5 (s) 85.1 (s)
6 132.7 (d) 132.7 (d) 33.0 (d) 131.8 (d) 133.5 (d)
7 132.4 (d) 132.4 (d) 30.5 (d) 131.5 (d) 130.5 (d)
8 41.4 (d) 40.6 (d) 49.8 (d) 52.0 (d) 49.8 (d)
9 48.0 (s) 48.0 (s) 48.9 (s) 45.5 (s) 48.9 (s)
10 40.6 (d) 41.4 (d) 37.9 (d) 38.8 (d) 36.1 (d)
11 30.5 (t) 30.5 (t) 30.4 (t) 30.8 (t) 30.4 (t)
12 39.4 (t) 39.1 (t) 39.1 (t) 39.4 (t) 39.4 (t)
13 37.2 (s) 38.0 (s) 37.1 (s) 37.2 (s) 37.1 (s)
14 48.5 (s) 48.5 (s) 47.9 (s) 48.6 (s) 48.0 (s)
15 33.5 (t) 33.5 (t) 33.5 (t) 33.2 (t) 33.5 (t)
16 27.9 (t) 27.9 (t) 27.8 (t) 27.9 (t) 27.8 (t)
17 49.4 (d) 50.0 (d) 50.1 (d) 49.9 (d) 50.1 (d)
18 14.71 (q) 14.71 (q) 15.01 (q) 14.91 (q) 15.01 (q)
19 105.4 (d) 105.4 (d) 114.7 (d) 79.8 (t) 114.7 (d)
20 36.1 (d) 36.2 (d) 36.2 (d) 36.1 (d) 37.9 (d)
21 18.7 (q) 18.6 (q) 18.6 (q) 18.7 (q) 18.7 (q)
22 27.1 (t) 30.0 (t) 27.1 (t) 27.3 (t) 27.1 (t)
23 128.3 (d) 125.2 (d) 125.3 (d) 128.3 (d) 128.4 (d)
24 136.8 (d) 139.6 (d) 139.5 (d) 136.8 (d) 136.8 (d)
25 74.9 (s) 70.7 (s) 70.7 (s) 74.8 (s) 74.9 (s)
26 26.2II (q) 29.8II (q) 30.0II (q) 26.1 II (q) 26.1 II (q)
27 25.8II (q) 27.1 II (q) 29.9II (q) 25.8II (q) 25.8II (q)
28 20.51 (q) 23.91 (q) 20.61 (q) 20.51 (q) 20.61 (q)
29 23.91 (q) 20.41 (q) 24.41 (q) 24.51 (q) 24.41 (q)
30 19.71 (q) 19.7I (q) 20.5 I (q) 20.01 (q) 19.91 (q)
OMe 50.3 (q) 57.3 (q) 50.3 (q) 57.3 (q)
OMe 50.3 (q)
NOTE: Assignments denoted I and II within any vertical column can be
interchanged.
Table 5. IH NMR data for compounds 1 and 2 (300MHz, CDCI3,
TMS as internal standard) All chemical shift values are



























NOTE: Assignments denoted I within any vertical column can be
interchanged
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Table 6. IH NNfR data for compounds 3,4,5,6, and 7 (300MHz, CDCl3,
TMS as internal standard) All chemical shift values are expressed
in ppm (0)
118
Proton Compound Compound Compound Compound Compound
3 4 5 6 7
1 1.41 1.47 1.34 1.32 1.45
2 1.65 1.68 1.57 1.61 1.72
3 3.38 3.40 3.41 3.31 3.48
6 6.06 6.06 6.10 6.00 6.07
7 5.65 5.65 5.50 5.60 5.50
8 2.82 2.82 2.13 2.32 2.24
10 2.45 2.45 2.29 2.18 2.15
11 1.61 1.61 1.52 1.51
12 1.82 1.65
15 1.38 1.35 1.39 1.31
16 1.94 1.92 1.92
17 1.40 1.30 1.41 1.38
18 0.831 0.831 0.831 0.831 0.831
19 5.11 5.10 4.40 3.65; 3.49 4.40
20 1.47 1.50 1.48 1.48 1.59
21 1.19 1.20 1.23 1.18 0.901
22 1.76 1.78 1.72 1.75 1.72
23 5.42 5.58 5.57 5.47 5.45
24 5.40 5.58 5.57 5.40 5.40
26 1.23 1.29 1.29 1.23 1.23
27 1.23 1.29 1.29 1.23 1.23
28 0.891 0.861 0.871 0.87! 0.871
29 0.85! 0.85! 0.841 0.851 0.861
30 0.871 0.87! 0.881 0.891 0.881
OMe 3.13 3.37 3.13 3.37
OMe 3.13
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Spectrum 19: Expanded COSY spectrum of [92]
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Spectrum 2e: DEPT spectnun of [93]
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Spectrum 3b: Infrared spectrum of [102]
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Spectnun 3e: DEPT spectrum of [102]
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Spectrum 4b: Infrared spectrum of [103]
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Spectrum 4e: DEPT spectrum of [103]
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Spectrum 4i: l3C NMR spectrum of [103a]
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Spectrum 6d: l3e NMR spectrum of [105]
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